Introduction {#s1}
============

Neuronal circuits are the basis for brain function. Therefore, the reconstruction of neuronal wiring diagrams is key to understanding circuit function. Fluorescence imaging has been a powerful approach in visualizing the three-dimensional structure of neuronal morphology. In particular, fluorescent proteins are useful for labeling genetically-defined neuronal populations. In recent years, a number of tissue-clearing methods have been developed, and these have been optimized for use with fluorescent proteins and deep-tissue antibody staining ([@bib12]; [@bib5]; [@bib17]; [@bib41]; [@bib36]). These new tools have expanded the scale of the available technologies for fluorescence imaging to whole-organ and whole-organism levels.

It is still difficult, however, to dissect and trace an individual neuron from a brain sample labeled with a single type of fluorescent protein. One way to overcome this problem is to improve the spatial resolution. Recently, we developed a tissue-clearing agent for high-resolution three-dimensional fluorescence imaging, named SeeDB2 ([@bib17]). SeeDB2 was designed to minimize spherical aberrations, allowing for high-resolution imaging including super-resolution microscopy. In this approach, there was much improvement in the z-resolution, a critical factor for dissection of neuronal fibers crossing over along the z-axis. Similarly, expansion microscopy is also a promising new approach used to improve resolution in three-dimensional fluorescence imaging ([@bib4]; [@bib24]; [@bib43]; [@bib3]).

Another approach to the dissection of neuronal circuits is multicolor labeling. To facilitate the dissection of individual neurons, a transgenic multicolor labeling method, Brainbow, has been developed, in which three different fluorescent proteins were expressed in a stochastic manner ([@bib27]; [@bib1]; [@bib28]). Brainbow used the Cre-loxP system to express one of the three fluorescent protein genes stochastically in a transgene. When multiple copies of the transgene cassette are introduced, stochastic choices will result in a combinatorial expression of these three genes with different copy numbers, producing dozens of color hues.

Although the Brainbow concept is powerful for discriminating between numerous neurons using light microscopy, the existing Brainbow methods are of limited use for neuronal tracing. This is because the stochastic and combinatorial expression of fluorescent proteins is possible only at low copy number ranges for the transgenes, so that the expression levels of the fluorescent proteins were not sufficiently high for bright and high-resolution imaging of axons and dendrites. Therefore, many of the previous studies were forced to use subsequent antibody staining to produce reliable neuronal tracing. In the present study, we utilized the Tet-Off system (Tetbow) to develop a multicolor labeling method with enhanced expression. As vector (plasmid and virus)-mediated gene transfer has become a versatile tool in modern neuroscience, we aimed to perform multicolor labeling using these tools. As a proof-of-concept experiment, we demonstrated the ability to trace axons of individual neurons on the scale of several millimeters in the mouse olfactory system. To improve the stability of the fluorescence labels after harsh tissue-clearing treatment, we also developed a Tetbow system with chemical tags. When combined with the advances in the growing field of tissue-clearing techniques, these new multicolor labeling strategies should facilitate neuronal tracing at higher densities and resolutions.

Results {#s2}
=======

A trade-off between expression levels and color variation {#s2-1}
---------------------------------------------------------

Earlier Brainbow methods utilized transgenic animals for stochastic multicolor labeling. They utilized the Cre-loxP system, in which DNA recombination resulted in a stochastic selection of one fluorescent protein gene out of three (or more) choices. When multiple copies of the Brainbow transgene were introduced into the genome, stochastic recombination produced a variety of color hues based on different copy numbers of expressed fluorescent protein genes (collectively called XFPs) ([@bib27]). In recent years, however, plasmid or virus vector-mediated gene transfer has become a more versatile strategy in neuroscience. We therefore tried to optimize a multicolor labeling method for vector-mediated gene transfer.

Previously, an adeno-associated virus (AAV)-mediated Brainbow method (AAV-Brainbow) has been reported ([@bib1]). However, in the vector-mediated gene transfer, the Cre-loxP system is not essential for the stochastic and combinatorial expression of XFP genes ([@bib22]; [@bib45]; [@bib39]). We can easily make color variations by introducing a mixture of three different XFP constructs: as long as the copy number of the introduced genes is small, labeled neurons will still produce a variety of colors irrespective of whether the Cre-loxP system is used or not ([Figure 1A--C](#fig1){ref-type="fig"}). It should be noted, however, that color variation reduces as the copy number of the introduced genes increases. We can estimate the optimum copy number of the introduced XFP genes as follows. We considered that the number of introduced genes will follow a Poisson distribution ([@bib22]). When three different XFP genes are introduced at 20 copies/cell/color on average, a similar number of copies will be introduced into each neuron, and only a small degree of color variation will be generated ([Figure 1C](#fig1){ref-type="fig"}). By contrast, if the copy number is too small, many of the neurons will express just one XFP gene ([Figure 1A](#fig1){ref-type="fig"}). When these three genes are introduced at an average 2 copies/cell/color, much larger color variations will be produced ([Figure 1B](#fig1){ref-type="fig"}).

![Tetbow strategy.\
Stochastic representation of the vector-mediated multicolor labeling strategy. Here we assume that the copy numbers of introduced vectors follow a Poisson distribution. In a plasmid or virus-mediated gene transfer method, we do not need to use the Cre-loxP system. Rather, it is important to limit the number of genes introduced into each cell. For example, in theory, an average of 2 copies/cell/color can result in the stochastic expression of three different genes (**B**). If we introduce a copy number that is too small (e.g. an average of 0.2 copies/cell; **A**), only one of the three genes will be expressed in most cells. If too many genes are introduced in each cell (e.g. an average of 20 copies/cell; **C**), color variations will be reduced because many of the neurons will express a similar number of XFP genes. The use of the Cre-loxP system alone cannot solve this problem. Simulations of the expected color variations that are based on the various Poisson distributions (middle) are shown as ternary plots (100 plots/condition, right panel). The numerical data are presented in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. Note that many of the plots are overlapping at the edge of the triangle in (A). Three different XFPs are shown in red (R), green (G), and blue (B). (**D**) The difference between two colors represented as Euclidean distance in 3D color space. For example, a difference between colors *a* and *b* is represented as the distance, *d*. (**E**) Box plots of Euclidean distances in all pairs of plots in 3D space in relation to copy number. The horizontal lines within each box represents the median, the box represents the interquartile range, and the whiskers show the minimum and maximum values. (**F**) A cartoon illustrating the cells inside (*X*%) and outside the threshold Euclidean distance. The cells outside (100 -- *X* %) are considered to be discernable. (**G**) The percentage of discernable cells for each threshold *d* and each copy number. Simulation data used for (**E**) and (**G**) are provided in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. (**H**) The color discrimination abilities of experienced researchers. Tests are explained in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. Mean ± SD are indicated in red. When threshold *d* is 0.1, the score was 94.5 ± 1.73% (mean ± SD). Score data are in [Figure 1---source data 2](#fig1sdata2){ref-type="supplementary-material"}.\
10.7554/eLife.40350.005Figure 1---source data 1.Simulation data used for [Figure 1E, G](#fig1){ref-type="fig"}.\
10.7554/eLife.40350.006Figure 1---source data 2.Color discrimination scores in [Figure 1H](#fig1){ref-type="fig"}.](elife-40350-fig1){#fig1}

We wanted to determine the optimum copy number of the expressed XFP genes on the basis of this simulation. We plotted the color values for cells in the color-coding space after intensity normalization (total intensity = 1). In this coding space, each dimension represents the intensity of one of the three colors (Red, Green, and Blue in pseudocolor representation). The mean Euclidean distance (*d*) for two randomly chosen cells was greater when the copy number was lower ([Figure 1D,E](#fig1){ref-type="fig"}), but this does not necessarily mean that we can discriminate between many cells, as the two cells are more likely to become the same color when copy number is too low ([Figure 1A](#fig1){ref-type="fig"}). We therefore calculated the probability that two randomly chosen cells are discriminated on the basis of a given threshold distance in the color-coding space. Here we considered that cells within the threshold distance (*d*) from a reference are indiscriminable in the color-coding space; cells outside of the threshold distance were considered discriminable from the reference ([Figure 1F](#fig1){ref-type="fig"}). In our simulation, when we assumed a threshold distance of 0.1, 95.3% of cells could be discriminated from a given cell when XFP genes were expressed at 2 copies/color/cell ([Figure 1G](#fig1){ref-type="fig"}). We also found that experienced researchers can discriminate two colors separated by 0.1 Euclidean distances in the color-coding space at 94.5 ± 1.73% accuracy (mean ± S.D.; [Figure 1H](#fig1){ref-type="fig"} and [Figure 1--- figure supplement 1](#fig1s1){ref-type="fig"}). Thus, \~2 copies/color/cell is the optimum when the color hues are judged visually by human experimenters.

We evaluated this prediction using the *in utero* electroporation of plasmid vectors into layer 2/3 cortical pyramidal neurons (electroporated at embryonic day 15). We introduced a mixture of three separate plasmid vectors encoding mTurquoise2 (blue), EYFP (green), and tdTomato (red) genes under a CAG promoter. When these plasmids were expressed at high copy numbers (CAG High; DNA solution introduced was 1 μg/μL/plasmid; 3 μg/μL in total; see \'Materials and methods\' section for details), only small color variations were produced ([Figure 2A,C](#fig2){ref-type="fig"}). When the DNA concentrations were reduced (CAG Low; 0.25 μg/μL/plasmid), the color variation increased ([Figure 2B](#fig2){ref-type="fig"}), but the overall fluorescence levels were much reduced ([Figure 2E](#fig2){ref-type="fig"}). Thus, there is a trade-off between the expression levels of fluorescent proteins and color variations, and this is the reason why the previous Brainbow methods were unable to produce color variations that were bright enough for labeling.

![Bright multicolor labeling can be produced by using fewer copy numbers of plasmids with a stronger promoter.\
(**A**) L2/3 neurons labeled with CAG-Turquoise2, EYFP, and tdTomato (1 or 0.25 μg/μL each). When each plasmid was introduced at 0.25 μg/μL, the color variation was increased, but the fluorescence levels were reduced. Enhanced images are shown on the right. (**B**) CAG-tTA, TRE- Turquoise2, EYFP, and tdTomato were introduced at 0.25 μg/μL each (Tetbow construct; see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). *In utero* electroporation was performed at E15 and the mice were analyzed at P21. Experiments were performed in parallel, and image acquisition conditions were the same for (**A**) and (**B**). Scale bars represent 50 μm. (**C, D**) Color variations made by three CAG vectors (**C**) vs. Tetbow vectors (**D**) are shown in ternary plots. Fluorescence intensities were vector normalized and the fluorescence intensity ratios were compared. Fluorescence intensities at neuronal somata were used for the quantitative comparison. Note that the color variations are small with high-copy CAG vectors, whereas color variations are high with the Tetbow vectors (n = 249--728 cells per group from three sets of experiments for each of the samples). Fluorescence intensity data used for (**C**), (**D**), and (**F**) are provided in [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}. (**E**) Boxplot of median EYFP fluorescence intensities (normalized to the median of CAG (0.25 µg/µl). A D'Agostino and Pearson Normality Test showed that the data were not normally distributed (p\<0.0001). EYFP signals in (**A**) and (**B**) were compared. The horizontal line in each box represents the median location, the box represents the interquartile range, and the whiskers show the minimum and maximum values. p\*\<0.05, p\*\*\*\<0.001 (Kruskal-Wallis with Dunn's post hoc test, n = 104--276 per sample). The data are from one set of experiments performed in parallel. We analyzed three independent sets of experiments and obtained similar results. The fluorescence intensity data used for (**E**) are in [Figure 2---source data 2](#fig2sdata2){ref-type="supplementary-material"}. (**F**) Percentage of discernable cells in the condition of each threshold *d* and each copy number. p\*\*\*\<0.001 (two-way ANOVA with Tukey-Kramer post hoc test, n = 249--728 per sample).\
10.7554/eLife.40350.010Figure 2---source data 1.Fluorescence intensity data used for C,[Figure 2C](#fig2){ref-type="fig"}, [D](#fig2){ref-type="fig"} and [F](#fig2){ref-type="fig"}.\
10.7554/eLife.40350.011Figure 2---source data 2.Fluorescence intensity data used for [Figure 2E](#fig2){ref-type="fig"}.](elife-40350-fig2){#fig2}

Tetbow: multicolor labeling with enhanced expression levels {#s2-2}
-----------------------------------------------------------

We therefore wanted to enhance the expression levels of fluorescent proteins while maintaining the required low copy numbers of XFP genes. Recent studies indicated that the tetracycline response element (TRE) promoter ensures much higher expression levels than the CAG promoter when expressed with a tetracycline trans-activator (tTA) ([@bib29]; [@bib37]). We therefore used the tTA-TRE (Tet-Off) system instead of a common CAG promoter. We also introduced a Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) sequence in the 3'′ UTR of XFP genes to improve their expression levels. Earlier Brainbow techniques used membrane-bound XFPs because unmodified XFPs labeled the somata too brightly and affected the tracing of nearby neurites ([@bib1]). However, this problem can be easily solved by minimizing spherical aberration in microscopy by using an index-matched clearing agent, SeeDB2 ([@bib18]). Furthermore, unmodified XFPs label axons and dendrites much more brightly than the membrane-bound ones (data not shown). We therefore used unmodified XFPs instead of membrane-bound XFPs. These new set of constructs (named Tetbow; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) achieved much higher XFP expression levels when compared with the CAG-promoter plasmids ([Figure 2B](#fig2){ref-type="fig"}). When we quantified the expression levels of EYFP, we observed a six-fold increase in fluorescence levels ([Figure 2E](#fig2){ref-type="fig"}; CAG 0.25 μg/μL vs. Tetbow 0.25 μg/μL; n = 104 and 260, respectively, p\<0.0001, Kruskal Wallis with Dunn's post hoc test). Tetbow allowed for much more robust multicolor labeling than the Brainbow constructs when introduced by *in utero* electroporation, allowing more reliable axon tracing ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

Owing to the enhanced expression, the Tetbow system achieved bright labeling ([Figure 2E](#fig2){ref-type="fig"}) while maintaining the color variations produced by low copy numbers of XFP genes. When CAG-XFP genes were introduced at high concentrations (1 μg/μL each), the color variations were small; by contrast, the Tetbow constructs (0.25 μg/μL) produced much larger variations ([Figure 2D](#fig2){ref-type="fig"}). In the color discrimination analysis, we confirmed that different cells are better discriminated by Tetbow than in the CAG High condition ([Figure 2F](#fig2){ref-type="fig"}).

We further tried to determine the optimum concentration of plasmids for Tetbow when labeled with *in utero* electroporation. Among the four plasmid concentrations we tested (0.05, 0.1, 0.25, and 0.5 μg/μL each), color discrimination performance was comparable. Paradoxically, however, the expression levels of XFP were the highest at 0.25 μg/μL each, not at 0.5. We therefore considered the possibility that a moderate expression level of tTA is critical for the optimum expression. When 0.1, 0.25, and 0.5 μg/μL of CAG-tTA plasmid was co-introduced with 0.25 μg/μL each of TRE-XFP plasmids, the highest expression level was found with 0.1 μg/μL CAG-tTA ([Figure 3D--F](#fig3){ref-type="fig"}). Thus, too high a concentration of tTA leads to the suppression of TRE-XFP genes. Consistent with this assumption, when the WPRE sequence was added to the CAG-tTA plasmid, the expression level of TRE-XFP genes was reduced ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Thus, the expression level of tTA needs to be moderate to achieve the highest expression of TRE-XFP genes.

![Optimization of Tetbow plasmid concentrations for *in utero* electroporation.\
(**A--C**) Plasmid concentrations for the four Tetbow vectors (CAG-tTA and three TRE-XFP vectors) were tested at 0.05, 0.1, 0.25, and 0.5 μg/μL. (**B**) Boxplot of median EYFP fluorescence intensities (normalized to the median of Tetbow (0.05 µg/µl)). A D'Agostino and Pearson normality test showed that the data were not normally distributed (p\<0.0001). The horizontal bar within each box represents the median fluorescence intensity, the box represents the interquartile range, and the whiskers show the minimum and maximum values. p\*\*\<0.01, p\*\*\*\<0.001 (Kruskal Wallis with Dunn's post hoc test, n = 273--524 per sample). (**C**) Percentage of discernable cells for each of the threshold *d* and dilution conditions. There was no significant difference between each *d *condition (two-way ANOVA with Tukey-Kramer post hoc test) (n = 273--524 per sample). The fluorescence intensity data used for (**B**) and (**C**) are available in [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}. (**D--F**) L2/3 neurons labeled with Tetbow. Only tTA concentrations were changed (0.1, 0.25, or 0.5 μg/μL). Decrease in tTA concentrations enhanced signal intensities. (**E**) Boxplot of median EYFP fluorescence intensities (normalized to the median of Tetbow (tTA: 0.5 µg/µl)). A D'Agostino and Pearson normality test showed that the data were not normally distributed (p\<0.0001). The horizontal bar within each box represents the median location, the box represents the interquartile range, and the whiskers show the minimum and maximum values. p\*\*\<0.01, p\*\*\*\<0.001 (Kruskal Wallis with Dunn's post hoc test, n = 356--414 per sample). (**F**) Percentage of discernable cells for each threshold *d* and each dilution condition. p\*\<0.05, p\*\*\*\<0.001 (two-way ANOVA with Tukey-Kramer post hoc test, n = 356--414 per sample). The fluorescence intensity data used for (**E**) and (**F**) are available in [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}.\
10.7554/eLife.40350.014Figure 3---source data 1.Source data for [Figure 3B,C](#fig3){ref-type="fig"}.\
10.7554/eLife.40350.015Figure 3---source data 2.Source data for [Figure 3E,F](#fig3){ref-type="fig"}.](elife-40350-fig3){#fig3}

High-resolution 3D imaging with tissue clearing {#s2-3}
-----------------------------------------------

We described the use of SeeDB2 as a tissue-clearing agent ([@bib18]). SeeDB2 is designed to minimize spherical aberrations for glycerol (SeeDB2G) or oil (SeeDB2S) immersion objective lenses, making high-resolution 3D imaging possible. Furthermore, various fluorescent proteins were best preserved in SeeDB2, much more so than in commercialized mounting media or other tissue-clearing agents ([@bib18]). In high-resolution imaging, we must obtain photons from a limited volume, and thus the fluorescence intensity must be sufficiently high. Therefore, the combination of Tetbow and SeeDB2 is ideal for high-resolution volumetric multicolor imaging.

We introduced Tetbow constructs into Layer 2/3 neurons in the cerebral cortex using *in utero* electroporation. After clearing with SeeDB2G, the fluorescence levels of XFPs with Tetbow were strong enough to allow visualization of the fine detail of neuronal morphology in 3D ([Figure 4A](#fig4){ref-type="fig"} and [Video 1](#video1){ref-type="video"}). When we analyzed adult brain slices (P70), detailed structures of dendritic spines ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, and [Video 2](#video2){ref-type="video"}) and axonal boutons ([Figure 4C](#fig4){ref-type="fig"}) were clearly visualized with Tetbow. It should be noted that we obtained these high-resolution images of synaptic structures using solely native fluorescence of XFPs, with no antibody staining.

![Tetbow labeling is bright enough for high-resolution imaging of synaptic structures.\
Volume rendering of Layer 2/3 cortical pyramidal neurons labeled with Tetbow (P70). *In utero* electroporation was used to label L2/3 neurons at E15. Brain slices were cleared with SeeDB2G and imaged with confocal microscopy. Different neurons were brightly labeled with different colors. Representative images are shown from four independent experiments. (**A**) Low- and high-magnification images in Layer 2/3 (45.16 μm thick). The four panels on the right indicate each of the three single channel fluorescence images. See also [Video 1](#video1){ref-type="video"}. (**B**) Dendrites and dendritic spines were brightly labeled with various colors with Tetbow. A volume-rendered image (18.65 μm thick) is shown. See also [Video 2](#video2){ref-type="video"}. (**C**) Axons and axonal boutons were clearly visualized with Tetbow. A volume rendered image (23.01 μm thick) is shown. Note that the synaptic-scale structures were clearly visualized with the native fluorescence of XFPs, without antibody staining. Scale bars are 20 μm (A, left) and 5 μm (A, right and B, **C**).](elife-40350-fig4){#fig4}

###### Layer 2/3 cortical pyramidal neurons labeled with Tetbow.

Tetbow plasmids were introduced at E15 and the cerebral cortex was analyzed at P70. See legends to [Figure 4A](#fig4){ref-type="fig"}.

10.7554/eLife.40350.018

###### High-magnification images of dendrites in Layer 2/3 cortical pyramidal neurons labeled with Tetbow.

Tetbow plasmids were introduced at E15 and the cerebral cortex was analyzed at P70. See legends to [Figure 4B](#fig4){ref-type="fig"}.

10.7554/eLife.40350.019

To evaluate the versatility of Tetbow, we also tested other types of neurons using *in utero* electroporation. For example, we were able to label brightly mitral and tufted (M/T) cells in the olfactory bulb with Tetbow. It is known that each glomerulus in the olfactory bulb is innervated by 20--50 M/T cells ([@bib17]; [@bib15]). When we looked at each glomerulus, dendrites from different mitral cells were clearly visualized and were distinguishable by their different colors ([Figure 5](#fig5){ref-type="fig"} and [Video 3](#video3){ref-type="video"}). Thus, Tetbow can be used to analyze the detailed dendrite wiring diagram of individual M/T cells, including 'sister' M/T cells, which are connected to the same glomerulus.

![Tetbow labeling in the olfactory bulb.\
M/T cells in the olfactory bulb (P7) were labeled with Tetbow. A volume-rendered image is shown (84.07 μm thick). Each mitral cell was labeled with unique colors facilitating the identification of individual neurons at high resolution. Note that dendritic tufts from different neurons are clearly distinguishable with different colors in the high-magnification image (bottom). Representative data from one out of three independent experiments are shown here. See also [Video 3](#video3){ref-type="video"}. Scale bars are 100 μm (top) and 20 μm (bottom). Fluorescence signals at M/T cell somata are intentionally saturated in this image so that the fine details of dendrites are better visualized.](elife-40350-fig5){#fig5}

###### Mitral cells of the olfactory bulb labeled with Tetbow.

Tetbow plasmids were introduced at E12 and the olfactory bulb samples were analyzed at P7. See legends to [Figure 5](#fig5){ref-type="fig"}.

10.7554/eLife.40350.021

Tetbow with chemical tags {#s2-4}
-------------------------

Aqueous tissue-clearing agents are useful for large-scale three-dimensional imaging with fluorescent proteins. However, to clear lipid-rich myelinated axons completely, harsh clearing treatments, such as the use of detergents, solvents, and heating, are inevitable ([@bib6]; [@bib5]; [@bib35]; [@bib41]; [@bib32]). Indeed, there is a trade-off between the transparency of the tissues and damage to the tissues and fluorescent proteins ([@bib17]; [@bib18]). For example, most of the solvent-based clearing methods, such as BABB, quench fluorescent proteins. To overcome this problem, chemical tags could be a promising alternative to fluorescent proteins ([@bib23]; [@bib42]). Genetically encoded chemical tags, such as SNAP, Halo, CLIP, and TMP form covalent bonds with their cognate substrate, and fluoresce with synthetic labels. The molecular weights of these ligands are relatively small, allowing easy penetration into thick tissues. Once they form covalent bonds with their substrates, the fluorescence remains stable even under harsh clearing conditions.

We tested Tetbow multicolor labeling with three different chemical tags, SNAP, Halo, and CLIP ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We introduced these three chemical tag genes into L2/3 cortical pyramidal neurons using *in utero* electroporation. Brains were fixed, and the three chemical tags were visualized with synthetic fluorescence labels: SNAP-Surface 488, HaloTag TMR Ligand, and CLIP-Surface 647, respectively ([Figure 6A](#fig6){ref-type="fig"}). Like fluorescent proteins, chemical tags allowed for the robust multicolor labeling of neurons using the Tetbow system ([Figure 6B](#fig6){ref-type="fig"}). Owing to the low molecular weight of the substrates, 1 mm-thick mouse brain samples were efficiently labeled ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). After tissue clearing with solvent-based tissue clearing agents, 3DISCO or BABB, fluorescent proteins were largely quenched (data not shown) ([@bib17]); synthetic fluorophores bound to chemical tags, however, were bright and stable under these clearing conditions ([Figure 6B](#fig6){ref-type="fig"}).

![Tetbow labeling with chemical tags.\
(**A**) Tetbow labeling with chemical tags. We used SNAP, CLIP, and Halo tags for Tetbow labeling. These chemical tags form covalent bonds with their substrates, which contain chemical fluorophores. These chemical labels are stable even under harsh clearing conditions. See [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} for plasmid construction. (**B**) L2/3 neurons labeled with SNAP, Halo, and CLIP tags were visualized with SNAP-Surface 488, HaloTag TMR Ligand, and CLIP-Surface 647 (P21), respectively. Brain tissue was cleared with SeeDB2G, BABB, or 3DISCO. Note that a fluorescent protein, mTurquoise2, was largely quenched by BABB and 3DISCO whereas chemical tags with synthetic dyes remained stable. Scale bars are 50 μm. Data for each condition were obtained from sections from the same animal. This process was replicated for three animals.](elife-40350-fig6){#fig6}

Tetbow AAVs {#s2-5}
-----------

AAVs are also becoming a versatile gene delivery tool in neuroscience. However, the size of the conventional Brainbow gene cassettes was too large to allow them to be packaged into an AAV vector (\<5 kb). For this reason, a previous study divided the Brainbow cassette into two separate AAVs with two XFP genes each, and employed Cre-loxP recombination ([@bib1]). As described above, however, the Cre-loxP system is not needed to achieve multicolor labeling using AAV-mediated gene expression. Using the Tetbow strategy (i.e. multiple AAV vectors with different XFP genes), we can solve the size problem, and achieve improved multicolor labeling using simplified DNA constructs.

We generated four separate AAV vectors carrying *SYN1*-tTA, TRE-mTurquoise2, TRE-EYFP, and TRE-tdTomato genes ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). The human *SYNI* promoter was used to express tTA specifically in neurons. These four AAV vectors (serotype AAV2/1) were injected into the cerebral cortex of adult mice (P56) and analyzed two weeks later. We found a stochastic and combinatorial expression of the encoded fluorescent proteins in Layer five neurons when injected at 4 × 10^8^ gc/mL of AAV-*SYN1*-tTA and 3 × 10^10^ gc/mL of AAV-TRE-XFPs ([Figure 7A](#fig7){ref-type="fig"}). As expected from our simulation ([Figure 1](#fig1){ref-type="fig"}), the virus titer was critical for producing color variations. Higher virus titers led to reduced color variations ([Figure 7B](#fig7){ref-type="fig"}, right). In the cerebral cortex, 1--3 × 10^10^ gc/mL of AAV-TRE-XFPs was found to be optimum on the basis of the resultant expression levels and color variations ([Figure 7C and D](#fig7){ref-type="fig"}), but the optimum range may be different for different cell types ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}), injection volumes, or virus serotypes. Expression levels were sufficiently high for high-resolution imaging of neuronal morphology, including the visualization of dendritic spines ([Video 4](#video4){ref-type="video"}). It should be noted, however, that the expression of Tetbow AAVs can lead to toxic effects on cellular functions after a prolonged incubation period, as a result of the extremely high levels of expression. For example, cortical neurons started to show an aggregation of XFPs and displayed morphological abnormalities 4 weeks after virus injection, whereas olfactory bulb neurons were best visualized at 4 weeks. Thus, the optimum incubation time may be different for different cell types.

![Tetbow labeling with AAVs.\
(**A**) Layer five pyramidal neurons in the cerebral cortex labeled with Tetbow AAVs. Tetbow AAVs (serotype AAV2/1) were injected at P56 and analyzed two weeks later. Brain slices were cleared with SeeDB2G. The images display the native fluorescence of XFPs under SeeDB2G clearing. Low- and high-magnification images (89 μm thick, volume rendering) are shown. Scale bars are 100 μm on the left, and 10 μm on the right. (**B**) The optimization of virus titer conditions. Various titers of TRE-mTurquoise2, TRE-EYFP and TRE-tdTomato (1 × 10^10^, 3 × 10^10^, 1 × 10^11^ gc/mL) were injected at P56 and analyzed two weeks later. The tTA titer was 4 × 10^8^ gc/mL throughout. (**C**) Boxplots of EYFP fluorescence intensities at the cell bodies (normalized to the median of 1 × 10^10^ gc/mL). A D'Agostino and Pearson normality test showed that the data were not normally distributed (p\<0.0001). The horizontal line within each box represents the median location, the box represents the interquartile range, and the whiskers represent the minimum and maximum values. p\*\<0.05, p\*\*\*\<0.001 (Kruskal-Wallis with Dunn's post hoc test, n = 163--220 per sample). (**D**) The percentage of discernable cells for each threshold *d* and each titer condition. p\*\<0.05, p\*\*\<0.01, p\*\*\*\<0.001 (two-way ANOVA with Tukey-Kramer post hoc test, n = 163--220 per sample). Fluorescence intensity data used for (**B**) to (**D**) are available in [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.40350.028Figure 7---source data 1.Fluorescence intensity data used for [Figure 7](#fig7){ref-type="fig"}B-D.](elife-40350-fig7){#fig7}

###### CA1 pyramidal neurons in the hippocampus labeled with Tetbow AAVs.

Tetbow AAVs were injected to the hippocampus at P56 and analyzed after two weeks. See legends to [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}.

10.7554/eLife.40350.029

Long-range axon tracing with Tetbow {#s2-6}
-----------------------------------

The bright multicolor labeling method, Tetbow, is particularly useful for the analysis of long-range axonal projection of a population of neurons. To test the utility of Tetbow, we focused on mitral and tufted (M/T) cells in the olfactory bulb, which project axons (up to several millimeters) to the olfactory cortex, including the anterior olfactory nucleus, olfactory tubercle, piriform cortex, cortical amygdala, and lateral entorhinal cortex. Previous studies have performed axon tracing on populations of M/T cells from glomeruli in the olfactory bulb using dye injections ([@bib33]; [@bib40]), but these studies could not fully dissect individual axons. Other studies performed single-cell axon tracing using hundreds of serial brain sections, but these analyses were highly laborious and time-consuming ([@bib10]; [@bib14]). Owing to these limitations, we do not yet understand fully how the odor inputs into individual M/T cells are conveyed to the olfactory cortex.

To examine the axonal projections of M/T cells from the olfactory bulb, we injected Tetbow AAVs into the mouse olfactory bulb. First, Tetbow AAVs were expressed in most of olfactory bulb neurons. When compared to single-color labeling, the stochastic and combinatorial expression of XFPs was helpful in improving tracing performance ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Efficient axon tracing was further facilitated by the local injection of Tetbow AAVs ([Figure 8A,B](#fig8){ref-type="fig"}). In the olfactory bulb, many types of neurons were labeled, but only M/T cells projected their axons to the olfactory cortex. To facilitate high-resolution fluorescence imaging with a limited working distance of the objective lens (20x, NA = 0.75, WD = 0.66 mm), we flattened the olfactory cortical area onto a glass slide ([@bib40]). After the fixation and tissue clearing, axons of individual M/T cells were clearly visualized with XFPs in the entire area of the olfactory cortex ([Figure 8D](#fig8){ref-type="fig"} and [Video 5](#video5){ref-type="video"}). The unique color hue was largely preserved at the average level, if not at a single-pixel resolution, from proximal to distal part in each axon ([Figure 8E](#fig8){ref-type="fig"}). Across the three image areas, the median Euclidean distance for the same neuron was 0.049 (interquartile range = 0.063, n = 34 pairs). The unique color hues and their consistency facilitated manual reconstruction of individual M/T cell axons in the olfactory cortex ([Figure 8F](#fig8){ref-type="fig"}, [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}, and [Video 6](#video6){ref-type="video"}). Highly divergent patterns of axonal collaterals were observed among labeled M/T cell axons, complementing earlier findings ([@bib33]; [@bib10]; [@bib40]).

![Long-range tracing of M/T cell axons with Tetbow AAVs.\
(**A**) M/T cells in the olfactory bulb were labeled with Tetbow AAVs. The Tetbow AAV cocktail (138 nL) was injected into a single location on the dorsal surface of the right olfactory bulb using a glass capillary. The virus was injected at P60 and mice were analyzed four weeks later. AAV titers were 4 × 10^8^ gc/mL for AAV2/1-*SYN1*-tTA2 and 3 × 10^10^ gc/mL each for AAV2/1-TRE-mTurquoise2-WPRE, AAV2/1-TRE-EYFP-WPRE, and AAV2/1-TRE-tdTomato-WPRE. (**B**) In the olfactory bulb, M/T cells and various types of interneurons were densely labeled with Tetbow. (**C**) In the olfactory cortex, only M/T cell axons were labeled with Tetbow AAVs. The ventral-lateral part of the brain was flattened to 700 μm thickness. After fixation and clearing, confocal images were taken with 20x objective lenses. The labeling density was lower in the olfactory cortex, so we could easily trace individual M/T cell axons. M/T cell axons were found in the all areas of the olfactory cortex, including anterior olfactory nucleus (AON), olfactory tubercle (OT), piriform cortex (anterior (APC) and posterior (PPC)), cortical amygdala (CA), and lateral entorhinal cortex (LEC). Maximal intensity projection images of confocal images are shown (379.89 μm). See also [Video 5](#video5){ref-type="video"}. (**D**) High-magnification versions of the images shown in (**C**). All of the axons that were found in both area (a) and (b) and that could be traced for \>1,000 μm were analyzed (14 axons). (**E**) Ternary plots of color codes in the axons highlighted in (**C**). Average color codes in each area (**a--c**) are shown. The color consistency is shown on the right. The color code was largely consistent across the areas except for a few axons (\#6, \#11 or \#12). The copy number may not be optimum in this sample, as the plots are not found in the periphery of the ternary plots. The fluorescence intensity data used for (**E**) are available in [Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"}. (**F**) Tracing and reconstruction of M/T cell axons. We terminated tracing when the labeled axons were interrupted by unlabeled gaps. Thus, our conservative tracing is most probably showing an underestimate of the entire wiring diagram. All of the axons that could be successfully traced for \>1,000 μm are shown. The maximum length of the traced axon was 6852.63 μm. A z-stacked image of the reconstruction is shown. Tracings of individual M/T cells are shown in [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}. See also [Video 6](#video6){ref-type="video"}. Scale bars are 1 mm.\
10.7554/eLife.40350.034Figure 8---source data 1.Fluorescence intensity data used for [Figure 8](#fig8){ref-type="fig"}E.\
10.7554/eLife.40350.033Figure 8---source data 2.Axon length data used for [Figure 8---figure supplement 1D](#fig8s1){ref-type="fig"}.](elife-40350-fig8){#fig8}

###### M/T cell axons sparsely labeled with Tetbow AAVs.

Tetbow AAVs were injected to the olfactory bulb at P60 and analyzed after four weeks. Volume-rendering images of the olfactory cortex are shown. See legends to [Figure 8](#fig8){ref-type="fig"}.

10.7554/eLife.40350.035

###### Reconstruction of M/T cells axons.

Traced M/T cell axons are separately shown. See legends to [Figure 8](#fig8){ref-type="fig"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}.

10.7554/eLife.40350.036

Discussion {#s3}
==========

Bright multicolor labeling of neurons using the Tet-Off system {#s3-1}
--------------------------------------------------------------

To achieve the stochastic expression of multiple fluorescent proteins, it is important to optimize the number of genes that are introduced per cell. We introduced a limited number of copies of plasmids or virus vectors into neurons to enable the stochastic expression of XFPs based on a Poisson distribution. To enhance the expression levels of XFPs, we utilized a Tet-Off system, in which the tetracycline trans-activator (tTA) binds to the TRE promoter to drive the expression of genes of interest. In this way, we achieved multicolor labeling with much-improved brightness. Previously, the electroporation and virus infection of the Brainbow construct introduced just a small number of genes per cell, and as a result, the fluorescence levels were not sufficiently high for reliable neuronal tracing ([@bib22]; [@bib8]) (see also [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). In fact, Brainbow methods often had to employ antibody staining to enhance the fluorescence signals ([@bib1]). However, our Tetbow strategy provides enhanced fluorescence, allowing for high-resolution imaging without the need for antibody staining. As a result, our Tetbow strategy has opened up a new opportunity for large-scale high-resolution neuronal tracing using tissue clearing.

Our Tetbow strategy also overcomes a size-limit problem associated with AAV vectors. As we introduced tTA and TRE-XFP gene cassettes with separate AAV vectors, DNA construction was also simplified. Using our Tetbow AAVs, we could clearly visualize different neurons with different color hues at synaptic resolution. It should be noted, however, that using the correct virus titer is critical for the generation of color variations. If the virus titer is too low, many of the labeled neurons will express just one XFP gene. By contrast, if the virus titer is too high, many of the labeled neurons will express all three genes at similar levels. Recently, another group employed a similar strategy using a Tet-Off system and a newly engineered AAV for intravenous transduction; but the brightness levels that they achieved were not as good as those provided by CAG vectors ([@bib2]). To achieve the highest expression levels of XFPs, the expression level of tTA needs to be optimized ([Figure 3](#fig3){ref-type="fig"}). The Tet-Off system is also useful for controling the sparseness of XFP expression; by simply diluting the tTA vector, the expression of XFP can be sparsened without affecting color variations ([@bib2]).

AAV- based Tetbow is useful for a relatively broad set of applications, including use in less genetically tractable model animals. For example, an AAV-based Tet-Off system has already been tested in the marmoset brain ([@bib37]). Like mice, these animals demonstrated high expression levels of fluorescent proteins when the Tet-Off system was used. Thus, our Tetbow strategy can be useful for neuronal tracing studies in various species including primates.

Multicolor labeling with chemical tags {#s3-2}
--------------------------------------

In the present study, we also extended the Tetbow method to include chemical tags. Current tissue clearing methods are intended for the use of fluorescent proteins, but chemical tags can become a good alternative to the fluorescent proteins. First, unlike fluorescent proteins, once labeled with synthetic fluorophores, chemical tags are stable under harsh clearing conditions. This means that we can have a broader choice of clearing methods, particularly for lipid-rich and thick tissues. Chemical tags may also be useful for expansion microscopy, where the stability of fluorescent proteins has been a challenging aspect ([@bib4]; [@bib24]; [@bib43]; [@bib3]). The fluorescence labeling of chemical tags is much easier than the antibody staining of XFPs ([@bib23]). Furthermore, synthetic fluorophores penetrate much deeper than antibodies because of their smaller size. Second, more choices of fluorescence spectrum and photochemical properties are available with chemical tags than with fluorescent proteins. For example, synthetic fluorophores cover the spectrum from UV to near-IR range, expanding the possible spectrum range when imaging. In addition, autonomously blinking fluorophores are very useful for localization-based super-resolution microscopy ([@bib44]). Multicolor 3D PALM/STORM imaging of cleared tissues would be an interesting possibility in the future.

Single-axon tracing for long-range axonal projections {#s3-3}
-----------------------------------------------------

In recent years, several tissue-clearing methods that are optimized for fluorescence imaging have been developed, expanding the imaging scale in light-microscopy-based neuronal tracing. However, the imaging resolution was not sufficiently high for densely labeled neuronal circuits. Therefore, we could only look at population-level connectivity ([@bib34]) or at a very small subset of neurons ([@bib7]) with light microscopy. To examine the projection diagram of individual neurons, a single-cell barcoding and RNA sequencing approach, MAPseq, has been proposed ([@bib20]). Although MAPseq is a promising new tool in the study of area-to-area connectivity for hundreds of neurons ([@bib13]), we cannot know the finer details of their neuronal morphology. Currently, saturated connectomics is only possible with electron microscopy ([@bib16]), but the analytical throughput is currently not sufficient for the study of long-range projections. The combination of Tetbow and tissue clearing can become a useful tool to fill the gap, allowing the dissection of densely labeled neurons at a large scale.

Limitations and future challenges {#s3-4}
---------------------------------

In the present study, we employed our Tetbow method to analyze axonal projection profiles for M/T cells in the mouse olfactory bulb ([Figure 8](#fig8){ref-type="fig"}). We were able to find labeled axons in all the areas of the olfactory cortices that we examined (piriform cortex, cortical amygdala, and lateral entorhinal cortex), but it remains unclear whether we could completely label all the fibers to their termini. In fact, it is extremely difficult to know whether the labeled termini are really termini or are interrupted by small unlabeled gaps. Even if the second scenario is very likely, it is difficult to know which segments are in fact connected to each other, but the variable color hues can help. Single-cell labeling is advantageous to avoid such ambiguity, although the throughput is limited for such analyses ([@bib14]). By contrast, multicolor labeling may be useful to compare the projection patterns in the same animals. In our analysis shown in [Figure 8F](#fig8){ref-type="fig"}, we traced axons using conservative criteria: we terminated tracing when labeled axons were interrupted by small gaps. Nevertheless, the quality of axonal tracing was comparable to that in earlier studies ([@bib33]; [@bib10]). To further improve the tracing performance (including up to the axon termini), it will be important to improve labeling methods in order to fill the thin neuronal fibers completely and evenly.

In this study, we employed manual neuronal tracing to Tetbow data, and were able to trace individual M/T cell axons successfully at the millimeter (\>6 mm) scale. Color hues were consistent at a global scale ([Figure 8E](#fig8){ref-type="fig"}), but not perfect in high-magnification images ([Figure 8D](#fig8){ref-type="fig"}). Chromatic aberration can also be a problem in the high-resolution imaging of thick tissues. Another important challenge will be to improve the color hue consistency throughout a neuron and to develop auto-tracing software that is optimized for the multicolor-labeled neurons.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\           Designation               Source or reference                  Identifiers                                                       Additional information
  (species) or resource                                                                                                                                    
  ----------------------- ------------------------- ------------------------------------ ----------------------------------------------------------------- ------------------------
  Gene\                   C57BL/6N                  Japan SLC                            RRID: [MGI:5658686](https://scicrunch.org/resolver/MGI:5658686)   
  (*Mus musculus*)                                                                                                                                         

  Gene\                   ICR                       Japan SLC                            RRID: [MGI:5652524](https://scicrunch.org/resolver/MGI:5652524)   
  (*Mus musculus*)                                                                                                                                         

  Cell line\              AAVpro 293 T Cell Line    Clontech                             cat\# 632273                                                      
  (*Homo sapiens*)                                                                                                                                         

  Recombinant\            pTRE-Tight                Clontech                             cat\# 631059                                                      
  DNA reagent                                                                                                                                              

  Recombinant\            pCAG-CreERT2              PMID: 17209010 ([@bib30])            Addgene\# 14797                                                   
  DNA reagent                                                                                                                                              

  Recombinant\            pmTurquoise2-N1           PMID: 22434194 ([@bib11];[@bib30])   Addgene\# 60561                                                   
  DNA reagent                                                                                                                                              

  Recombinant\            pBluescript II SK(+)\     Agilent Technologies                 cat\# 212205                                                      
  DNA reagent             phagemid                                                                                                                         

  Recombinant\            paavCAG-pre-\             PMID: 22138823 ([@bib21])            Addgene\# 34910                                                   
  DNA reagent             mGRASP-mCerulean                                                                                                                 

  Recombinant\            pSNAPf                    New England Biolabs                  cat\# N9183S                                                      
  DNA reagent                                                                                                                                              

  Recombinant\            pCLIPf                    New England Biolabs                  cat\# N9215S                                                      
  DNA reagent                                                                                                                                              

  Recombinant\            pFC14K HaloTag\           Promega                              cat\# G3780                                                       
  DNA reagent             CMV Flexi Vector                                                                                                                 

  Recombinant\            pCAG-mTurquoise2          This paper                           N/A                                                               
  DNA reagent                                                                                                                                              

  Recombinant\            pCAG-EYFP                 This paper                           N/A                                                               
  DNA reagent                                                                                                                                              

  Recombinant\            pCAG-tdTomato             This paper                           N/A                                                               
  DNA reagent                                                                                                                                              

  Recombinant\            pCAG-tTA                  This paper                           Addgene\# 104102                                                  
  DNA reagent                                                                                                                                              

  Recombinant\            pBS-TRE\                  This paper                           Addgene\# 104103                                                  
  DNA reagent             -mTurquoise2-WPRE                                                                                                                

  Recombinant\            pBS-TRE-EYFP-WPRE         This paper                           Addgene\# 104104                                                  
  DNA reagent                                                                                                                                              

  Recombinant\            pBS-TRE-td\               This paper                           Addgene\# 104105                                                  
  DNA reagent             Tomato-WPRE                                                                                                                      

  Recombinant\            pBS-TRE-SNAPf-WPRE        This paper                           Addgene\# 104106                                                  
  DNA reagent                                                                                                                                              

  Recombinant\            pBS-TRE-CLIPf-WPRE        This paper                           Addgene\# 104107                                                  
  DNA reagent                                                                                                                                              

  Recombinant\            pBS-TRE-HaloTag-WPRE      This paper                           Addgene\# 104108                                                  
  DNA reagent                                                                                                                                              

  Recombinant\            AAV2-miniSOG\             PMID: 23889931 ([@bib26])            Addgene\# 50970                                                   
  DNA reagent             -VAMP2-tTA-mCherry                                                                                                               

  Recombinant\            pAAV-*SYN1*-tTA           This paper                           Addgene\# 104109                                                  
  DNA reagent                                                                                                                                              

  Recombinant\            pAAV-TRE\                 This paper                           Addgene\# 104110                                                  
  DNA reagent             -mTurquoise2-WPRE                                                                                                                

  Recombinant\            pAAV-TRE\                 This paper                           Addgene\# 104111                                                  
  DNA reagent             -EYFP-WPRE                                                                                                                       

  Recombinant\            pAAV-TRE\                 This paper                           Addgene\# 104112                                                  
  DNA reagent             -tdTomato-WPRE                                                                                                                   

  Recombinant\            pCAG-iCre                 PMID: 26972009 ([@bib18])            N/A                                                               
  DNA reagent                                                                                                                                              

  Recombinant\            AAV-EF1a-BbTagBY          PMID: 23817127 ([@bib1])             Addgene\# 45185                                                   
  DNA reagent                                                                                                                                              

  Recombinant\            AAV-EF1a-BbChT            PMID: 23817127 ([@bib1])             Addgene\# 45186                                                   
  DNA reagent                                                                                                                                              

  Commercial\             AAVpro Helper\            Takara                               cat\# 6673                                                        
  assay or kit            Free System                                                                                                                      

  Commercial\             AAVpro Purification\      Takara                               cat\# 6666                                                        
  assay or kit            Kit (All Serotypes)                                                                                                              

  Commercial\             AAVpro Titration Kit\     Takara                               cat\# 6233                                                        
  assay or kit            (for real-time PCR)                                                                                                              

  Chemical\               SNAP-Surface 488          New England Biolabs                  cat\# S9124S                                                      
  compound, drug                                                                                                                                           

  Chemical\               CLIP-Surface 647          New England Biolabs                  cat\# S9234S                                                      
  compound, drug                                                                                                                                           

  Chemical\               HaloTag TMR Ligand        Promega                              cat\# G8252                                                       
  compound, drug                                                                                                                                           

  Chemical\               Saponin                   Nakalai-tesque                       cat\# 30502--42                                                   
  compound, drug                                                                                                                                           

  Chemical\               Omnipaque 350             Daiichi-Sankyo                       cat\# 081--106974                                                 
  compound, drug                                                                                                                                           

  Chemical\               Urea                      Wako                                 cat\# 219--00175                                                  
  compound, drug                                                                                                                                           

  Chemical\               N,N,N\',N\'-Tetrakis\     TCI                                  cat\# T0781                                                       
  compound, drug          (2-hydroxypropyl)\                                                                                                               
                          ethylenediamine                                                                                                                  

  Chemical\               Triton X-100              Nakalai-tesque                       cat\# 12967--45                                                   
  compound, drug                                                                                                                                           

  Chemical\               Hexane                    Nakalai-tesque                       cat\# 17922--65                                                   
  compound, drug                                                                                                                                           

  Chemical\               Benzyl alcohol            SIGMA                                cat\# 402834--100 ML                                              
  compound, drug                                                                                                                                           

  Chemical\               Benzyl benzoate           Wako                                 cat\# 025--01336                                                  
  compound, drug                                                                                                                                           

  Chemical\               Tetrahydrofuran,\         Wako                                 cat\# 207--17905                                                  
  compound, drug          super dehydrated,\                                                                                                               
                          with stabilizer                                                                                                                  

  Chemical\               Dibenzyl Ether            Wako                                 cat\# 022--01466                                                  
  compound, drug                                                                                                                                           

  Software,\              ImageJ                    NIH                                  RRID: [SCR_003070](https://scicrunch.org/resolver/SCR_003070)     
  algorithm                                                                                                                                                

  Software,\              GraphPad Prism 7          GraphPad Software                    RRID: [SCR_002798](https://scicrunch.org/resolver/SCR_002798)     
  algorithm                                                                                                                                                

  Software,\              MATLAB                    MathWorks                            RRID: [SCR_001622](https://scicrunch.org/resolver/SCR_001622)     
  algorithm                                                                                                                                                

  Software,\              Leica Application\        Leica Microsystems                   RRID: [SCR_013673](https://scicrunch.org/resolver/SCR_013673)     
  algorithm               Suite X                                                                                                                          

  Software,\              Imaris                    Bitplane AG                          RRID: [SCR_007370](https://scicrunch.org/resolver/SCR_007370)     
  algorithm                                                                                                                                                

  Software,\              Neurolucida               MBF Bioscience                       RRID: [SCR_001775](https://scicrunch.org/resolver/SCR_001775)     
  algorithm                                                                                                                                                

  Software,\              Adobe Photoshop           Adobe                                RRID: [SCR_014199](https://scicrunch.org/resolver/SCR_014199)     
  algorithm                                                                                                                                                

  Software,\              Adobe Illustrator         Adobe                                RRID: [SCR_010279](https://scicrunch.org/resolver/SCR_010279)     
  algorithm                                                                                                                                                

  Other                   Microslicer               Dosaka EM                            PRO7N                                                             

  Other                   Electroporator            BEX                                  CUY21EX                                                           

  Other                   Forceps-type\             BEX                                  LF650P5                                                           
                          electrodes\                                                                                                                      
                          (5 mm diameter)                                                                                                                  

  Other                   Forceps-type\             BEX                                  LF650P3                                                           
                          electrodes\                                                                                                                      
                          (3 mm diameter)                                                                                                                  

  Other                   TCS SP8X                  Leica Microsystems                   TCS SP8X                                                          

  Other                   10x dry lens              Leica Microsystems                   HC PL APO 10x/0.40 CS                                             

  Other                   20x multi-immersion\      Leica Microsystems                   HC PL APO 20x\                                                    
                          objective lens                                                 /0.75 IMM CORR CS2                                                

  Other                   40x oil-immersion\        Leica Microsystems                   HC PL APO 40x OIL CS2,                                            
                          objective lens                                                                                                                   

  Other                   63x glycerol-immersion\   Leica Microsystems                   HC PL APO 63x\                                                    
                          objective lens                                                 GLYC CORR CS2                                                     

  Other                   Raw image data            This paper                           <http://ssbd.qbic.riken.jp/set/20180901/>                         

  Other                   Neurolucida\              This paper                           <http://ssbd.qbic.riken.jp/set/20180901/>                         
                          reconstruction data                                                                                                              

  Other                   MATLAB codes              This paper                           <https://github.com/mleiwe/TetbowCodes>                           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plasmids  {#s4-1}
---------

pCAG-mTurquoise2/EYFP/tdTomato were assembled by using pCAG-CreERT2 (Addgene \#14797, RRID: [Addgene_14797](https://scicrunch.org/resolver/Addgene_14797), from Dr. Cepko), pmTurquoise2-N1 (Addgene \#60561, RRID: [Addgene_60561](https://scicrunch.org/resolver/Addgene_60561), from Dr. D. Gadella), EYFP (Clontech), and tdTomato (a gift from Dr. R. Tsien). To generate a backbone vector for pTRE-XFP, an *Xho-Xho* fragment containing TRE-SV40 poly A was transferred from pTRE-Tight (\#631059, Clontech) to pBluescript II SK(+) (\# 212205, Agilent) to ensure high-copy expression in *Escherichia coli*. The WPRE sequence was PCR amplified from an aavCAG-pre-mGRASP-mCerulean vector (Addgene \#34910, RRID: [Addgene_34910](https://scicrunch.org/resolver/Addgene_34910), a gift from Dr. J. Kim). The tTA sequence in pCAG-tTA and pAAV2-*SYN1*-tTA was derived from the tTA2 section of the pTet-Off Advanced vector (Clontech). SNAP~f~ and CLIP~f~ tag genes were obtained from New England Biolabs (\#N9183S, \#N9215S), and the HaloTag gene was obtained from Promega (\#G3780). AAV2-Tetbow vectors were generated by modifying AAV2-miniSOG-VAMP2-tTA-mCherry (Addgene \#50970, RRID: [Addgene_50970](https://scicrunch.org/resolver/Addgene_50970), from Dr. R. Tsien). Maps for the Tetbow plasmids are shown in figure supplements. The Tetbow plasmids and their sequences have been deposited at Addgene (<https://www.addgene.org/Takeshi_Imai/>) with Addgene \#104102--104112. See also **SeeDB Resources** (<https://sites.google.com/site/seedbresources/>) for updated information.

As for the Brainbow experiments, we used AAV-EF1a-BbTagBY (Addgene \#45185, RRID: [Addgene_45185](https://scicrunch.org/resolver/Addgene_45185)) and AAV-EF1a-BbChT (Addgene \#45186, RRID: [Addgene_45186](https://scicrunch.org/resolver/Addgene_45186)) plasmids.

Mice {#s4-2}
----

All animal experiments were approved by the Institutional Animal Care and Use Committee of the RIKEN Kobe Institute and Kyushu University. ICR mice (Japan SLC, RRID: [MGI](https://scicrunch.org/resolver/MGI): 5652524) were used for *in utero* electroporation and C57BL/6N mice (Japan SLC, RRID: [MGI](https://scicrunch.org/resolver/MGI): 5658686) were used for AAV experiments (age, P56-70; male). To obtain brain tissue, mice were i.p. injected with an overdose of nembutal (Dainippon Sumitomo Pharma) or somnopentyl (Kyoritsu Seiyaku) to produce deep anesthesia, followed by an intracardiac perfusion with 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS). Excised brain samples were post-fixed with 4% PFA in PBS at 4°C overnight. Samples were then embedded in 4% agarose and cut into slices of 220, 500, or 1000 μm thick with a microslicer, PRO7N (Dosaka EM).

*In utero* electroporation {#s4-3}
--------------------------

The *in utero* electroporation of plasmids to the cerebral cortex and mitral cells was performed as described previously ([@bib38]; [@bib17]; [@bib31]). Pregnant ICR mice were anesthetized with medetomidine (0.3 mg/kg), midazolam (4 mg/kg), and butorphanol (5 mg/kg), or with ketamine (100 mg/kg) and xylazine (10 mg/kg). The uterine horns carrying embryos were exposed through a midline abdominal incision. To label L2/3 neurons in the cortex, 1 μL of plasmid solutions diluted in PBS was injected into the lateral ventricle of the embryos at E15 using a micropipette made from a glass capillary. Electric pulses (single 10 ms poration pulse at 72 V, followed by five 50 ms driving pulses at 40--42 V with 950 ms intervals) were delivered by a CUY21EX electroporator (BEX) and forcep-type electrodes (5 mm diameter, \#LF650P5, BEX). To introduce pCAG-XFP vectors, the labels pCAG-mTurquoise2, EYFP, and tdTomato were injected into the lateral ventricle and electroporated at high-copy (1 μg/μL each, 3 μg/μL in total) or low-copy (0.25 μg/μL each, 0.75 μg/μL in total) numbers. pTRE-XFP vectors with pCAG-tTA were injected and electroporated at low-copy numbers (0.25 μg/μL each, 1.0 μg/μL in total) when not specified; in [Figure 3](#fig3){ref-type="fig"}, the exact plasmid concentrations are specified. To label mitral cells in the olfactory bulb, *in utero* electroporation was performed at E12. Electric pulses (single 10 ms poration pulse at 72 V, followed by five 50 ms driving pulses at 36 V with 950 ms intervals) were delivered with forceps-type electrodes (3 mm diameter, \#LF650P3, BEX). After the electroporation, the uterine horns were placed back into the abdominal cavity, and the abdominal wall and skin were sutured.

AAV {#s4-4}
---

AAV vectors were generated using the AAVpro Helper Free System (AAV1, \#6673, Takara) from Takara and the AAVpro 293 T cell line (\#632273, Clontech) following the manufacturers' instructions. The backbone pAAV plasmid is for AAV2. Thus, the serotype used in this study is AAV2/1. AAV vectors were generated by AAVpro 293 T cells (\#632273, Clontech). AAVpro 293T is a commercialized cell line for production of AAV vectors. We did not test for mycoplasma contamination in our hands. In our experiments, cells within 10 passages were used for virus production. AAV vectors were purified using the AAVpro Purification Kit All Serotypes (\#6666, Takara). Virus titers were then determined by qPCR using the AAVpro Titration Kit (\#6233, Takara) and the StepOnePlus system (ThermoFisher). To infect the AAV vectors, C57BL/6 mice (P56-70) were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg), and an AAV virus cocktail was injected into the brain using the nanoject II system and glass capillaries (\#3-00-203-G/XL, Drummond). The injection volume was 207 nL in [Figure 7](#fig7){ref-type="fig"}, 138 nL in [Figures 8](#fig8){ref-type="fig"}, and 207 nL ×5 different locations in [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}. The final concentration of the virus cocktail was 4 × 10^8^ gc/ml for AAV2/1-*SYN1*-tTA2 and 1 × 10^10^--1 × 10^11^ gc/mL each for AAV2/1-TRE-mTurquoise2-WPRE, AAV2/1-TRE-EYFP-WPRE, and AAV2/1-TRE-tdTomato-WPRE. The mice were sacrificed 2 or 4 weeks after viral injection. It should be noted that the expression of Tetbow AAV can lead to toxic effects for cellular functions after prolonged incubation because of the extremely high levels of expression. For example, cortical neurons started to show aggregation of XFPs and morphological abnormality 4 weeks after virus injection. Olfactory bulb neurons were best visualized 4 weeks after virus injection without obvious sign of toxicity. The optimum timing for the analysis may be different for different cell types.

The following stereotaxic coordinates were used for AAV injection. Distance in millimeters from the Bregma for the anterior (A) -- posterior (P), and lateral (L) positions, and from the brain surface toward the ventral (V) directions are indicated. Cortical layer five neurons: P=1.5, L = 1.5, V = 0.5; hippocampal CA1 neurons: P=1.5, L = 1.5, V = 1; olfactory bulb granule cells: A = 4.5, L = 0.5, V = 0.5; olfactory bulb M/T cells: A = 4.5, L = 0.5, V = 0.3.

Staining chemical tags {#s4-5}
----------------------

SNAP, CLIP, and HaloTags were visualized with their substrates, SNAP-Surface 488 (\#S9124S, New England Biolabs), HaloTag TMR Ligand (\#G8252, Promega), CLIP-Surface 647 (\#S9234S, New England Biolabs), respectively. Brain slices of 220 or 1000 μm thickness were incubated with the substrates (2 μM each) in 2 ml 2% saponin in PBS overnight. The slices were then washed with PBS (3 × 30 min).

Clearing with SeeDB2G {#s4-6}
---------------------

Brain-slice samples were cleared with SeeDB2G for imaging when not specified. SeeDB2G is designed for high-resolution imaging with glycerol-immersion objective lenses ([@bib18]). PFA-fixed brain samples (embedded in agarose, cut at 220, 500, or 1000 μm thick) were cleared at room temperature (25°C) with a 1:2 mixture of Omnipaque 350 (\#081--106974, Daiichi-Sankyo) and H~2~O with 2% saponin (\#30502--42, Nakalai-tesque) for 6 hr (3 ml in 5 ml tube), a 1:1 mixture of Omnipaque 350 and H~2~O with 2% saponin for 6 hr, and finally Omnipaque 350 with 2% saponin overnight. Cleared samples were then mounted in SeeDB2G (Omnipaque 350) on a glass slide using a 0.2 mm thick silicone rubber sheet (AS ONE, \#6-9085-13, Togawa rubber) and glass coverslips (\#0109030091, Marienfeld, No. 1.5H) ([@bib18]). A detailed step-by-step protocol has been published in bio-protocol ([@bib19]).

To quantify the fluorescence intensity of M/T cell axons ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), whole-brain samples were cleared with SeeDB2 and placed on a glass-bottomed dish for imaging and quantification.

To analyze long-rage axonal projection of M/T cells ([Figure 8](#fig8){ref-type="fig"}), a right-brain hemisphere was dissected, and the dorsal part and subcortical matter was trimmed away with forceps and a scalpel. The remaining part, containing all of the olfactory cortical areas, was flattened with a 700 mm spacer and fixed with 4% PFA in PBS overnight ([@bib40]). Then, the sample was treated with ScaleCUBIC-1 (25% (wt/wt) urea (\#219--00175, Wako), 25% (wt/wt) N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine (\#T0781, TCI), and 15% (wt/wt) Triton X-100 (\#12967--45, Nakalai-tesque) in H~2~O) ([@bib41]) for 24 hr to remove lipids from the lateral olfactory tract, washed with PBS, and then cleared with SeeDB2G as described above.

BABB {#s4-7}
----

PFA-fixed brain samples were serially incubated in 50%, 80%, and 100% ethanol, each for 8 hr. They were then incubated in 100% ethanol for 12 hr, and then in hexane (\#17922--65, Nakalai-tesque) for 12 hr. Samples were cleared (benzyl alcohol (\# 402834--100 ML, SIGMA):benzyl benzoate (\#025--01336, Wako)=1:2) with gentle shaking for 24 hr.

3DISCO {#s4-8}
------

PFA-fixed brain samples were serially incubated in 50%, 70%, 80%, and 100% tetrahydrofuran (THF, \# 207--17905, Wako), each for 1 hr. They were then incubated in 100% THF for 12 hr, and then in dibenzyl ether (DBE, \#022--01466, Wako) for 3 hr ([@bib9]).

Confocal imaging {#s4-9}
----------------

Confocal images were acquired using an inverted confocal microscope, TCS SP8X with HyD detectors (Leica Microsystems). Type G immersion (refractive index 1.46, Leica) was used for a 20x multi-immersion objective lens (HC PL APO 20x/0.75 IMM CORR CS2, NA0.75, WD 0.66 mm) and a 63x glycerol-immersion objective lens (HC PL APO 63x GLYC CORR CS2, NA1.3, WD 0.28 mm). Type F immersion (refractive index 1.518, Leica) was used for a 40x oil-immersion objective lens (HC PL APO 40x OIL CS2, NA1.3, WD 0.24 mm). Low-magnification images in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} were taken with a 10x dry lens (HC PL APO 10x/0.40 CS, NA0.4, WD 2.2 mm). Diode lasers of 442 or 448 nm, 488 nm, and 552 nm wavelength were used for mTurquoise2, EYFP, and tdTomato, respectively. In some experiments, a white light laser was used to image mTurquoise2, EYFP, and tdTomato. To image chemical tags, SNAP-Surface 488, HaloTag TMR Ligand, and CLIP-Surface 647 were imaged with diode lasers of 488 nm, 552 nm, and 638 nm wavelength, respectively. Emission light was dispersed by a prism and detected by HyD detectors.

Image processing and quantification {#s4-10}
-----------------------------------

Microscopy data were processed and visualized with LAS X (RRID: [SCR_013673](https://scicrunch.org/resolver/SCR_013673), Leica Microsystems) or Imaris (RRID: [SCR_007370](https://scicrunch.org/resolver/SCR_007370), Bitplane). Image data were excluded from further quantitative analyses when the data contained saturated fluorescence signals. For [Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, the fluorescence intensities on somata were quantified with ImageJ at every 2.97 μm thickness. For [Figure 7](#fig7){ref-type="fig"}, an image of the soma was taken and analyzed at the focal depth for each cell. For [Figure 8](#fig8){ref-type="fig"}, color values at axons were analyzed for maximum intensity projection images, as there may be a slight chromatic aberration along the z axis. After binarization, the average color value ratio was determined for each segment of each axon. Ternary plots, box plots, and statistical analyses were prepared using MATLAB (RRID: [SCR_001622](https://scicrunch.org/resolver/SCR_001622), MathWorks). Image data were acquired by RS, to prevent bias when they were subsequently analyzed by MNL. First, the fluorescence intensity in each channel was normalized so that the median intensity was 1. Then, the intensity values were further normalized so that the length of the vector was 1. Raw quantification data (Source Data files) are accompanied with figures. The MATLAB code and processed data for the figure panels have been deposited to GitHub ([@bib25]; copy archived at <https://github.com/elifesciences-publications/TetbowCodes>).

Axon tracing {#s4-11}
------------

Axon tracing was performed with Neurolucida (RRID: [SCR_001775](https://scicrunch.org/resolver/SCR_001775), MBF Bioscience). In [Figure 8F](#fig8){ref-type="fig"}, we focused on axons were found within 200 μm of the anterior end of the image. We terminated tracing when labeled axons were interrupted by unlabeled gaps; in such cases, we judged that we cannot be 100% sure whether the interrupted segments are connected. Thus, our tracing was performed using very conservative criteria, and thus most probably provides an underestimate of the entire wiring diagram. Axons that can be traced for \>1,000 μm were analyzed (25 axons). Putative mitral and tufted cells were identified on the basis of the projection area (piriform cortex vs. olfactory tubercle) and their axonal trajectories. Brightly-labeled putative mitral and tufted cells were further analyzed in [Figure 7D,E](#fig7){ref-type="fig"}. For [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}, we focused on axons that crossed the anterior plane and within the lateral half. We chose 100 axons in an unbiased manner from the dorsal to ventral direction. The criteria for successful tracing are described in [Figure 8D](#fig8){ref-type="fig"}; as these criteria are very strict, the area that is traced may be an underestimate. Color discrimination was performed visually by one experimenter, who also joined the visual color discrimination test.

Visual color discrimination {#s4-12}
---------------------------

Custom MATLAB code ([@bib25]; copy archived at <https://github.com/elifesciences-publications/TetbowCodes>) was written to quantify the ability of experienced researchers to discriminate three color space (RGB) in terms of 3D Euclidean space. All of the subjects (from the Imai lab) have experience in fluorescence imaging, understand the purpose of the test, and have trichromatic color vision. To prevent the intensity of the color from influencing the decision, the intensity was randomly varied between 50--100% for each square displayed ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The subject was presented with a choice to discriminate between two colors at a specified Euclidean distance. Specifically, they were asked to determine whether the two columns form a cross or a parallel line. For each Euclidean distance presented, there were 100 trials per subject, with the average success rate stored. Note that this test was not intended to evaluate the color discrimination performance of people in general.

Modeling {#s4-13}
--------

Poisson distributions were calculated in MATLAB, by creating independent distributions for each XFP for each specified copy number. 200 'cells' were selected for each copy number group with associated XFP values derived from the Poisson distributions. The code has been deposited to GitHub ([@bib25]; copy archived at <https://github.com/elifesciences-publications/TetbowCodes>).

Imaging data {#s4-14}
------------

The raw microscopy data have been deposited to the Systems Science of Biological Dynamics (SSBD) database (<http://ssbd.qbic.riken.jp/>) with a unique URL (<http://ssbd.qbic.riken.jp/set/20180901/>). Movies will be posted at SeeDB Resources (<https://sites.google.com/site/seedbresources/>).

Step-by-step protocol {#s4-15}
---------------------

Step-by-step protocols has been posted in our website, **SeeDB Resources** (<https://sites.google.com/site/seedbresources/>). All of our published clearing methods and technical tips are also posted on this website. A detailed protocol for SeeDB2 was published in bio-protocol ([@bib19]).
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Data availability {#s7}
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Raw microscopy data have been deposited to Systems Science of Biological Dynamics (SSBD) database (<http://ssbd.qbic.riken.jp/>) with a unique URL (<http://ssbd.qbic.riken.jp/set/20180901/>). MATLAB code and processed data for figure panels have been deposited to GitHub (<https://github.com/mleiwe/TetbowCodes>; copy archived at <https://github.com/elifesciences-publications/TetbowCodes>). A Source data file includes numerical data.

The following dataset was generated:

RichiSakaguchiMarcusN LeiweTakeshiImai2018A set of imaging data of neuronal circuits labeling with fluorescent proteins in M. musculusSystems Science of Biological Dynamics20180901
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Tetbow: bright multicolor labeling of neuronal circuits with fluorescent proteins and chemical tags\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Moritz Helmstaedter as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor.

Our decision has been reached after consultation between the reviewers.

Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered for publication in *eLife* at this point. However, if you are able to provide the additional experiments outlined below, we would be willing to consider a revised manuscript. This decision reflects the fact that *eLife* does not allow reviewers to suggest new experiments that are likely to take longer than 2 months to perform for a revision decision. By instead rejecting these manuscripts, we leave it up to the authors to decide if they think the reviewers are essentially correct, in which case, they may wish to do the requested experiments. If, however, they do not agree with the reviewers, then we would expect authors to send the paper elsewhere. Of course, if you already have the requested experiments in hand, we would be very pleased to have a revised manuscript, incorporating those new data immediately.

Your manuscript reports an approach for bright multicolor labeling of neurons with the goal of deducing neuronal circuitry. While the reviewers see a benefit of this technology over existing techniques, the following points would need to be added to the manuscript to satisfy the consensus concerns of the reviewers (see below for unedited original reviews):

1\) While it may seem plausible that an improvement of color distinction and/or brightness of labeling and/or constancy of colors were achieved, a clear application demonstrating the advance over existing techniques is missing. The reviewers suggest either of the following two proof-of-principle reports:

\- Quantitative report of long-distance (millimeters) color constancy when labeling axons.

\- Automated / efficient reconstruction of single neurons over longer distances, quantification that this reconstruction is performing better with TetBow than with previous techniques.

2\) The implications of the technique for circuit reconstruction (connectomics) should be described more cautiously: in local dense networks, the fluorescent labeling of neurons alone does not allow the inference of synaptic connectivity. For long-range labeling, the situation is more benign. We would ask that you amend the text accordingly and discuss this, also in light of the requested proof-of-concept application (see point 1).

Without a proof-of-principle experiment showing clearly the advance of the method over existing technology, the evaluation of the manuscript would be substantially less positive.

Reviewer \#1:

The manuscript \"Tetbow: bright mutlicolor labeling of neuronal circuits with fluorescent proteins and chemical tags\" by Sakaguchi et al. reports the development of a multicolor neuronal labelling toolbox that uses the Tetracyclin-operator system instead of the Cre-loxP system used for the \"Brainbow\" technology. The main claim of the manuscript is that this different approach increases color variability and provides enhanced color intensity. While an improvement over the \"Brainbow\" technology for neuron labelling is a relevant endeavour.

I see the following key concerns with the manuscript:

1\) The notion of wiring diagram and circuits is mistaken when all that is provided is an intracellular labelling of a presynaptic neuronal population. Wiring diagrams imply synapse detection which this method is currently not providing. This has to be made very clear and care should be taken not to confuse the terminology. Still, intense and long-range labelling of a large number of presynaptic neurons can contribute to circuit analysis and in this sense the method could be valuable.

2\) While the manuscript contains many beautiful images, a quantitative documentation of long-range color constancy is missing. In this reviewer\'s opinion the long-range color constancy is a key prerequisite to use multicolor labelling methods at the light level for circuit inference. While locally the detection of synapses is absolutely required to distinguish an incidental from a synaptic contact, millimeters away from the source neuron, circuit inference can be plausibly done by judging the projection target regions of presynaptic neurons. However, for this the neurons have to stay brightly labelled over millimeters if not centimeters in larger brains. This needs to be documented and quantified for this approach to make a substantial advance.

3\) Related to point 2, it would be necessary to show a clear, at least potential improvement in terms of interpretation of such data. Some proof of concept application would be required -- at least a hypothetical one. This does not imply that for a methods manuscript a full result has to be documented but at least the notion of what this kind of result could be and why this method in contrast to previous methods will be able to achieve this. Again, I would suggest using the long-range circuit inference as one of these possible key applications.

In summary I think this is an interesting methodological advance that however so far lacks clear quantitative documentation of long-range color constancy. The enhancement of color space is impressive but without a clear application difficult to judge in terms of its impact for neuroscience.

Reviewer \#2:

In this article the authors present a useful variation of Brainbow strategy for stochastic multicolor labeling of neurons. Their method, which they called Tetbow, combines the Tet-Off system with the Brainbow approach. They show that they can generate multicolor labeling using plasmids for XFPs or chemical tags as well as with viral tools. These reagents will be a useful addition to the already available recombinase based or transgenic toolkit for multicolor labeling. However, the authors\' major claim that the expression levels of FPs using this approach is much higher, therefore this strategy \'should facilitate neuronal circuit reconstruction at higher densities and resolutions\' compared to the current -best of class- Brainbow approaches is not supported by the data presented. Labeling many neurons in a brain and labeling individual neurons bright enough for complete reconstructions is a challenging problem. But it is not clear from the data presented that the approach presented in this manuscript solves this problem.

Specific comments:

1\) The conditions for induction of the Tet-Off system need to be described in the Materials and methods section.

2\) It is not clear from the description why the 0.25µg/µl was chosen for the in utero electroporations. Were multiple concentrations tried? Was the chosen concentration arrived at after examining spread (colors) or by looking at ternary plots as in Figure 2D.

3\) Subsection "Image processing and quantification", subsection "Modeling", subsection "Imaging data", include code and data location.

4\) Figure 2 panel D -- the ternary plot could be separated out for the three conditions for clarity.

5\) Figure 1---figure supplement 1 seems unnecessary -- addresses a special case of Brainbow.

6\) Figure 2---figure supplement 1 and Figure 2---figure supplement 2 can be condensed together; the plasmid cartoons again could be condensed. Similarly, for the other plasmid and vector maps.

7\) Figure 2---figure supplement 3 -- Brainbow 3.0 experiment is uninformative.

Reviewer \#3:

In this manuscript, Sakaguchi et al., present a toolbox for multicolor neuronal labeling termed \"Tetbow\". Their approach relies on mixing three distinct vectors that express different colors of fluorescent protein (cyan, yellow or red) with the Tet-Off system. Each fluorescent protein gene is under the control of a tetracycline response element (TRE), activated by a transactivator (tTA2) encoded by a fourth vector. The authors show that this strategy enables multicolor labeling of mouse neurons by in utero electroporation, and provide evidence that higher expression and more color contrast can be achieved with Tet-Off transactivation compared with direct expression of the fluorescent proteins from a CAG promoter. They also present a variation of their technique in which protein tags (SNAP, Halo and CLIP) are used to label neurons with combinations of synthetic fluorochromes resistant to tissue clearing procedures. Finally, they present a version of Tetbow based on AAV vectors, which also achieves multicolor labeling of neurons in injected brain areas.

The tools presented in the manuscript may be of interest for the neuroscience community and several convincing images are provided that support their effectiveness. I have however several general concerns about the manuscript:

First, most of the concepts used in the paper are not new. For instance, multicolor labeling with mixtures of vectors expressing distinct XFPs has been introduced several years ago (Weber et al., 2011), as has been the usage of AAV vectors (Cai et al., 2013) or electroporation (Loulier et al., 2014) to achieve multicolor neuronal labeling, and the modeling of the relation between copy number and color combinations (Kobiler et al., 2010).

Second, beyond the images presented in the article, there is no demonstration of a usage of the Tetbow approach to trace connectivity. An application of these strategies to study some aspects of brain circuitry is essential to evaluate their usefulness. In particular it appears uncertain that labeled neuronal processes can be followed in their entirety in neural tissue samples.

Third, due to incomplete description or inappropriate evaluation procedures, the actual improvement brought by Tetbow appears uncertain. For instance, it is unclear if the number of samples analyzed in Figure 1 is sufficient to minimize discrepancies among the different brains analyzed, and between different sections of a given brain. The authors also claim that their scheme is simpler that Brainbow, but in practice this is hardly the case: with Tetbow, a total of 4 plasmids or AAV vectors must be introduced in neurons of interest, while with Brainbow two plasmids (Brainbow et al., 2014) or 2 AAVs (AAV no. 1 and no. 2, Cai et al., 2013) are sufficient. In addition, with Tetbow, careful titration of the different color vectors needs to be performed for each fresh vector preparation, while expression of different XFPs is intrinsically balanced in Brainbow transgenes, making them inherently more reproducible. Concerning the strategy based on protein tags (Figure 5), one cannot assess how deep synthetic fluorochromes labels diffuse within tissue sections: does this scheme really enable to label more than just the first few 10th of micrometers of tissue samples? Finally, are Tetbow protein tags (Figure 5) and AAVs (Figure 6) more efficient in terms of expression level and color contrast than standard vectors? It seems that most cells in Figure 5 and Figure 6 coexpress all three XFPs and that the color contrast in these samples is low.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Tetbow: bright multicolor labeling of neuronal circuits with fluorescent proteins and chemical tags\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Eve Marder (Senior Editor), a Reviewing Editor, and three reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

While the reviewers were very positive about the extensive revision, they concluded after extended discussion that they would strongly recommend to address the following remaining issues. These will likely not require an additional consultation with the reviewers after submission of the final revision.

\- The text needs substantial revision along the suggestions of reviewers 2 and 3, especially to properly reference the literature and remove ambiguous statements.

\- We recommend describing the quality of terminal axonal branch labeling, since this is considered a key benchmark of this set of methods.

Reviewer \#1:

This manuscript is a revision of an earlier submission. The authors have taken serious steps to address the issues raised before and have in my view substantially improved the manuscript. The case for Tetbow being a significant step forward for multi-color neuronal labeling has been made more clearly.

In particular, I think the added analyses of color assessment, comparison of fluorescence intensity to Brainbow; and importantly the analysis of color constancy over long distances (Figure 8 and associated supplements) are valuable and relevant.

*Reviewer \#2:*

The revised manuscript, Tetbow: bright mutlicolor labeling of neuronal circuits with fluorescent proteins and chemical tags\" by Sakaguchi et al., addresses some of the points raised by the reviewers in the previous submission however, one significant concern remains.

This methods paper adds to the existing toolkit for multicolor labeling of neurons. The tTA-*TRE* based reagents described in this manuscript appear to have improved brightness over the traditional Brainbow methods. While such a color palette would certainly be useful for answering certain neuroanatomical questions the revised manuscript still fails to address the primary concern that was raised in the original submission -- whether such a multicolor labeling approach would be useful for complete neuronal reconstructions. Will the use of multicolor labeling permit reconstruction of entire neurons at higher densities as the authors suggest, i.e. is it an improvement over existing methods that simply use sparse and bright neuronal labeling with a limited color-set.

Figure 8 and Figure 8---figure supplement 2 in this revised submission address this question. The data presented clearly show that the trajectories of the main axon of multiple M/T neurons can be traced. This might be useful if the goal was to identify the primary brain areas targeted by these neurons. But it is not at all clear from the data shown whether complete reconstructions of neurons would be feasible and therefore prompts the question if Tetbow labeling is bright enough to trace axonal arbors in entirety. Reconstructions that aim to trace out only the main axon and the first order collaterals are already possible even in Thy1-GFP transgenic animals (see for instance Guo et al., (2017)). The authors would have definitely compared their traced neurons to the Mitral/Tufted cell reconstructions presented in Igarashi, 2012 or Ghosh, 2011 (both articles are cited in the manuscript). Is it possible to get similar level of completeness using the Tetbow approach?

Reviewer \#3:

Sakaguchi et al., present a revised version of their article on the development of an enhanced multicolor neuronal labeling toolbox termed \"Tetbow\". They have significantly strengthened their study, with the addition of: (1) a theoretical analysis of the color discriminability expected with their labeling scheme; (2) a more precise characterization of the effects of plasmid and AAV concentrations and ratios on color labels; (3) examples of axon tracing over long distances in mitral cells labeled with AAV mixtures. This latter point constituted the main insufficiency of the initial draft of the article, and is addressed in a relatively convincing manner, although an evaluation of the applicability of chemical tags for tracing is still lacking. The tools presented in the manuscript and the efforts made at characterizing optimal labeling conditions will be of interest for the neuroscience community.

My main comment about this new version of the article concerns the presentation of the results, which requires significant revision of the text for the following reasons:

\- Several concepts presented in the article are not novel per se and are simply improved and more deeply explored than in the studies that introduced them. The true interest of the article lies in these improvements and optimizations, which will undoubtedly be useful to the community, not in the rediscovery of previous ideas. This is for instance the case of multicolor labeling with mixtures of distinct single-color viral vectors (Chan et al., 2017; Weber et al., 2011) or plasmids (Siddiqi et al., 2014), modeling of the relationship between copy number and color (Kobiler et al., 2010), usage of the Tet-Off system to amplify expression in a multicolor context (Chan et al., 2017 and other studies)...When introducing these concepts, the text should state this explicitly and refer to the related articles. It is with respect to these recent studies that the new tools should be judged, not only relative to former Cre-dependent Brainbow approaches.

\- The discussion should also include a section on the drawbacks of Tetbow and possible difficulties of this approach, such as the necessity to carefully titrate the different RGB vectors to equilibrate their concentration, batch-to-batch variations, and whether it is compatible with strategies to sparsen expression e.g. as in Chan et al., 2017.

-Some statements are repeated unnecessarily throughout the paper (e.g. the known fact that Cre recombination is not required for combinatorial labeling).

\- Several sentences are quite imprecise, some conclusions are overstated and there are also many typos that need to be corrected.

10.7554/eLife.40350.042

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> \[...\] 1) While it may seem plausible that an improvement of color distinction and/or brightness of labeling and/or constancy of colors were achieved, a clear application demonstrating the advance over existing techniques is missing. The reviewers suggest either of the following two proof-of-principle reports:
>
> \- Quantitative report of long-distance (millimeters) color constancy when labeling axons.
>
> \- Automated / efficient reconstruction of single neurons over longer distances, quantification that this reconstruction is performing better with TetBow than with previous techniques.

We agree that it is important to demonstrate the capabilities of our bright multicolor-labelling method, Tetbow. Particularly, proof-of-principle experiments such as tracing long-range axonal projections would be helpful. In our new sets of experiments, we focused on mitral and tufted (M/T) cells in the olfactory bulb (OB), which project axons (up to \~6 mm long) to the olfactory cortices, including the olfactory tubercle, piriform cortex, cortical amygdala, and lateral entorhinal cortex. When we labeled M/T axons with Tetbow, axon collaterals of M/T cells were clearly visualized in the piriform cortex; however, published Brainbow constructs could not clearly label these axons in the same condition (Figure 2---figure supplement 2).

Automated circuit tracing is obviously an important future direction using Tetbow; however, it is far beyond the scope of the current submission to develop and include auto-tracing software. Instead, we performed manual tracing. To evaluate the performance of our manual tracing objectively, we examined the color discrimination performance of researchers (Figure 1---figure supplement 2). We confirmed that we can visually discriminate color hues with 0.1 Euclidian distance in a C-Y-R color coding space with \>90% accuracy (Figure 1H). In that situation, one cell can be successfully discriminated from \~90% of random cells (Figure 1G).

We then evaluated the performance of Tetbow for manually tracing M/T cell axons. In one experiment (Figure 8), we injected AAV-Tetbow locally. In another experiment (Figure 8---figure supplement 2), we injected the same virus cocktail to the entire dorsal OB densely. Tracing was performed after tissue clearing. In the local injection experiments, only dozens of M/T cells were labelled, and these axons were clearly distinguishable from each other and could be traced into the olfactory cortex (Figure 8). Each M/T cell demonstrated a unique branching pattern in the cortex (Figure 8---figure supplement 1), supplementing previous studies that used laborious single-axon tracing (Nagayama et al., 2010; Sosulski et al., 2011; Ghosh et al., 2011; Igarashi et al., 2012). Notably, the unique color hue was maintained from proximal to distal part of M/T cell axons, allowing for reliable manual tracing (Figure 8C). In the second experiment (dense labeling), most of M/T cells in the dorsal OB were labelled (Figure 8---figure supplement 2A); however, these axons were dissociated and traced for hundreds of microns based on color hues, which was impossible with single-color labeling (Figure 8---figure supplement 2B, C). Together, we concluded that our Tetbow method allows for long-range axonal tracing (at several millimeters scale) in cleared tissues at unprecedented reliability.

> 2\) The implications of the technique for circuit reconstruction (connectomics) should be described more cautiously: in local dense networks, the fluorescent labeling of neurons alone does not allow the inference of synaptic connectivity. For long-range labeling, the situation is more benign. We would ask that you amend the text accordingly and discuss this, also in light of the requested proof-of-concept application (see point 1).

We agree that our method cannot validate synaptic connectivity, while synaptic structures such as dendritic spines and axon boutons can be clearly visualized. We also understand that some researchers use "connectomics" or "wiring" strictly for synapses, whereas others use them also for mesoscopic and macroscopic levels from an area to another area. In the new experiments for tracing long-range projections, we merely analyzed the branching patterns of individual M/T cells. To avoid unnecessary confusions, we amended the text accordingly. We have changed "connectomics" to "neuronal tracing".

> Reviewer \#1:
>
> \[...\] 1) The notion of wiring diagram and circuits is mistaken when all that is provided is an intracellular labelling of a presynaptic neuronal population. Wiring diagrams imply synapse detection which this method is currently not providing. This has to be made very clear and care should be taken not to confuse the terminology. Still, intense and long-range labelling of a large number of presynaptic neurons can contribute to circuit analysis and in this sense the method could be valuable.

We thank this reviewer for recognizing utility of our new method. To avoid any possible confusions, we amended the text, as explained above.

> 2\) While the manuscript contains many beautiful images, a quantitative documentation of long-range color constancy is missing. In this reviewer\'s opinion the long-range color constancy is a key prerequisite to use multicolor labelling methods at the light level for circuit inference. While locally the detection of synapses is absolutely required to distinguish an incidental from a synaptic contact, millimeters away from the source neuron, circuit inference can be plausibly done by judging the projection target regions of presynaptic neurons. However, for this the neurons have to stay brightly labelled over millimeters if not centimeters in larger brains. This needs to be documented and quantified for this approach to make a substantial advance.
>
> 3\) Related to point 2, it would be necessary to show a clear, at least potential improvement in terms of interpretation of such data. Some proof of concept application would be required -- at least a hypothetical one. This does not imply that for a methods manuscript a full result has to be documented but at least the notion of what this kind of result could be and why this method in contrast to previous methods will be able to achieve this. Again, I would suggest using the long-range circuit inference as one of these possible key applications.

We agree and have performed analysis of long-range projections focusing on M/T cells, as detailed above. We also evaluated the reliability of manual (visual) neuronal tracing (Figure 1H).

> In summary I think this is an interesting methodological advance that however so far lacks clear quantitative documentation of long-range color constancy. The enhancement of color space is impressive but without a clear application difficult to judge in terms of its impact for neuroscience.

We appreciate the enthusiasm on our manuscript. In the revised manuscript, we added a new analysis of M/T cell projection (Figure 8). The projection patterns of M/T cells from the OB to the olfactory cortex have been a big mystery for many years. While several studies tried axonal tracing from the OB to the olfactory cortex (Nagayama et al., 2010; Sosulski et al., 2011; Ghosh et al., 2011; Igarashi et al., 2012) and partially revealed the logic, single axon tracing has been still laborious. We believe that with our new strategy (a combination of Tetbow labeling and tissue clearing) should open an opportunity for producing and studying a more comprehensive map of long-range axonal projection.

> Reviewer \#2:
>
> \[...\] These reagents will be a useful addition to the already available recombinase based or transgenic toolkit for multicolor labeling. However, the authors\' major claim that the expression levels of FPs using this approach is much higher, therefore this strategy \'should facilitate neuronal circuit reconstruction at higher densities and resolutions\' compared to the current -best of class- Brainbow approaches is not supported by the data presented. Labeling many neurons in a brain and labeling individual neurons bright enough for complete reconstructions is a challenging problem. But it is not clear from the data presented that the approach presented in this manuscript solves this problem.

In our previous manuscript, we compared the brightness and color variability using CAG-XFP and Tetbow constructs. We believe that this is a fair comparison, as we used the same amount of plasmids containing the same fluorescent proteins. We, however, understand that it is also important to perform a side-by-side comparison with the current -best of class- Brainbow constructs for realistic samples. To address this issue, we introduced Brainbow AAV plasmids (Cai et al., 2013) and Tetbow plasmids (this study) into M/T cells using *in utero* electroporation. It should be noted that only EYFP is shared between two methods, and the other fluorescent proteins are different.

We analyzed three samples each. As for Tetbow, we could clearly visualize M/T cell axons in the olfactory cortex, millimeters away from the OB. However, we could not recognize any axonal signals in our two Brainbow samples, and we could only detect faintly dotted signals for one sample (Figure 2--- figure supplement 2). As we could not recognize axons in 2/3 samples, we cannot evaluate fluorescence intensity quantitatively. However, these results clearly demonstrate the improved neuronal tracing ability of Tetbow. Single axon tracing is also shown in Figure 8. Thus, our method solved the problem.

To demonstrate the power of mulcicolor labeling strategy, we also compared tracing performance for multicolor vs single color (artificially produced from the multicolor data) using densely-labelled challenging sample (Figure 8---figure supplement 1). The result was quite obvious as expected.

> Specific comments:
>
> 1\) The conditions for induction of the Tet-Off system need to be described in the Materials and methods section.

The Tet-Off system does not require DOX administration. We simply co-expressed tTA2 with TRE-XFPs. The plasmid amount or virus titer is detailed in the Materials and methods section.

> 2\) It is not clear from the description why the 0.25µg/µl was chosen for the in utero electroporations. Were multiple concentrations tried? Was the chosen concentration arrived at after examining spread (colors) or by looking at ternary plots as in Figure 2D.

We examined four different concentrations of the Tetbow plasmids (0.05, 0.1, 0.25, 0.5 µg/µL). As for the color discriminability, we introduced a new evaluation metric in the revised manuscript. We examined how likely two randomly chosen cells can be discriminated based on color dissimilarity (Euclidian distance in a color coding space). As the discriminability is determined by the threshold Euclidian distance, we examined discriminability at various threshold levels. To place this in context, the accuracy of human vision was also tested. In manual (human vision) recognition, the threshold level was \~0.1 (Figure 1H). In terms of color discriminability, there was no significant difference among the four conditions (Figure 3A-C). To our surprise, the intensity of fluorescent proteins was highest at 0.25µg/µL, not 0.5. We therefore used 0.25µg/µL for the *in utero* electroporation.

We further examined why 0.25 was better than 0.5, and found that a lower concentration of tTA is preferred for higher expression levels of TRE-XFPs (Figure 3D-F). It is possible that an excessive amount of tTA interferes with the transcription machinery. Based on this finding, we also omitted the WPRE sequence for tTA plasmids, and it performed better without WPRE.

> 3\) Subsection "Image processing and quantification", subsection "Modeling", subsection "Imaging data", include code and data location.

All of the codes developed in this study will be uploaded to GitHub. Link to the unique GitHub site will be included in the final manuscript as well as in our website, SeeDB Resources. Similarly, all of the plasmids have been deposited to Addgene (https://www.addgene.org/Takeshi_Imai/). All of the raw image data will be deposited to SSBD database (http://ssbd.qbic.riken.jp/set/20180701/).

> 4\) Figure 2 panel D -- the ternary plot could be separated out for the three conditions for clarity.

The ternary plots are now separately shown in Figure 2C, D.

> 5\) Figure 1---figure supplement 1 seems unnecessary -- addresses a special case of Brainbow.

As advised, we deleted the old Figure 1---figure supplement 1.

> 6\) Figure 2---figure supplement 1 and Figure 2---figure supplement 2 can be condensed together; the plasmid cartoons again could be condensed. Similarly, for the other plasmid and vector maps.

In our understanding, supplementary figures will not be included in the PDF version, and only seen online linked to each main figure. We therefore think that each figure supplement should be separate in *eLife*. Please advise us if we are wrong.

> 7\) Figure 2---figure supplement 3 -- Brainbow 3.0 experiment is uninformative.

We performed the Brainbow3.0 experiment, as this was one of the best Brainbow cassettes published so far (Cai et al., 2013). The conclusion is that fluorescence was too weak for neuronal tracing with Brainbow3.0. However, it is true that Brainbow3.0 expresses mOrange2, EGFP, and mKate, none of which is used in Tetbow. To answer this reviewer's request, we performed new experiments using another set of Brainbow plasmids, which contain EYFP (Cai et al., 2013). This result is now in new Figure 2---figure supplement 2. Again, the fluorescence was too weak for neuronal tracing in this condition.

> Reviewer \#3:
>
> \[...\] The tools presented in the manuscript may be of interest for the neuroscience community and several convincing images are provided that support their effectiveness. I have however several general concerns about the manuscript:
>
> First, most of the concepts used in the paper are not new. For instance, multicolor labeling with mixtures of vectors expressing distinct XFPs has been introduced several years ago (Weber et al., 2011), as has been the usage of AAV vectors (Cai et al., 2013) or electroporation (Loulier et al., 2014) to achieve multicolor neuronal labeling, and the modeling of the relation between copy number and color combinations (Kobiler et al., 2010).

We are fully aware of all of these publications and, of course, have cited them in our initial submission. The major improvement introduced in this study is the enhanced expression with Tet-Off system. Furthermore, the result was qualitatively different. In the published methods, we could not clearly visualize fine axons without antibody staining. Therefore, they were not sufficiently powerful for large-scale analysis. However, with our new Tetbow strategy, we could trace millimeter-long axons after tissue clearing. We thus believe that our method is a major breakthrough toward large-scale neuronal tracing.

> Second, beyond the images presented in the article, there is no demonstration of a usage of the Tetbow approach to trace connectivity. An application of these strategies to study some aspects of brain circuitry is essential to evaluate their usefulness. In particular it appears uncertain that labeled neuronal processes can be followed in their entirety in neural tissue samples.

To address this point, we have performed new experiments, which are now in Figure 8. At the very least, Tetbow-labelled axons were found in entire regions of the olfactory cortex (olfactory tubercle, piriform cortex, cortical amygdala, and lateral entorhinal cortex).

> Third, due to incomplete description or inappropriate evaluation procedures, the actual improvement brought by Tetbow appears uncertain. For instance, it is unclear if the number of samples analyzed in Figure 1 is sufficient to minimize discrepancies among the different brains analyzed, and between different sections of a given brain.

The old Figure 1 only contains simulation results. If this reviewer meant Figure 2, we analyzed three brains each. In our new Figure 3F, we indicate three different brain samples separately in circles. There was no discrepancy among samples.

> The authors also claim that their scheme is simpler that Brainbow, but in practice this is hardly the case: with Tetbow, a total of 4 plasmids or AAV vectors must be introduced in neurons of interest, while with Brainbow two plasmids (Brainbow et al., 2014) or 2 AAVs (AAV no. 1 and no. 2, Cai et al., 2013) are sufficient. In addition, with Tetbow, careful titration of the different color vectors needs to be performed for each fresh vector preparation, while expression of different XFPs is intrinsically balanced in Brainbow transgenes, making them inherently more reproducible.

We examined whether careful titration of the different color vectors are critical in our method. Both in simulation based on Poisson distribution (Figure 1G) and actual experiments (Figure 3 for plasmids; Figure 7 for AAVs); a 3-5-fold difference did not produce a big difference. These new sets of experiments demonstrate that Tetbow is highly reproducible, irrespective of small changes in plasmid amount or virus titers.

Of course, when the copy number is too high, the color variation will decrease, but this is also the case for Brainbow.

> Concerning the strategy based on protein tags (Figure 5), one cannot assess how deep synthetic fluorochromes labels diffuse within tissue sections: does this scheme really enable to label more than just the first few 10th of micrometers of tissue samples?

Compared to antibodies, which are really huge, the molecular weights of chemical tag substrates are very small. To demonstrate efficient penetration or chemical tags, we stained 1mm-thick brain slices expressing chemical tags in layer 2/3 neurons. After staining with fluorescent substrates, the entire thickness was clearly visualized with fluorescent labels (Figure 6---figure supplement 2).

> Finally, are Tetbow protein tags (Figure 5) and AAVs (Figure 6) more efficient in terms of expression level and color contrast than standard vectors? It seems that most cells in Figure 5 and Figure 6 coexpress all three XFPs and that the color contrast in these samples is low.

In terms of color variation and consistency, they are basically the same. In the chemical tag strategy, one protein tag reacts with just one substrate molecule. Thus, the brightness does not improve a lot, compared to the fluorescent proteins. More spectral variation is one advantage, as is already mentioned in the Discussion section. AAV can indeed enhance the expression level when compared to plasmids. This point is now mentioned in the Results section.

As the expression levels of XFPs are extremely high with the AAV Tetbow, XFPs start to aggregate and neurons start to die several weeks after virus injection. We sacrificed animals 2-4 weeks after injection, before these morphological damages emerge. This point is also clarified in the text.

\[Editors\' note: the author responses to the re-review follow.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> While the reviewers were very positive about the extensive revision, they concluded after extended discussion that they would strongly recommend to address the following remaining issues. These will likely not require an additional consultation with the reviewers after submission of the final revision.

We thank all the reviewers for careful and constructive reviews.

> \- The text needs substantial revision along the suggestions of reviewers 2 and 3, especially to properly reference the literature and remove ambiguous statements.

According to the reviewers' suggestions, we have amended the text.

> \- We recommend describing the quality of terminal axonal branch labeling, since this is considered a key benchmark of this set of methods.

We agree that it is a major interest for the readership in neuroscience community. However, it is almost impossible to know whether the labeled terminal are the real terminals or those that have been interrupted by technical reasons. This is true for any tracing techniques including EM-based connectomics. Therefore, there is no definitive tool to distinguish these two possibilities. Instead, we have clarified the following two points in the revised text.

1\) We clarified the criteria as to how we determined the terminal of the tracing. In our analysis in Figure 8, we terminated tracing when axon labeling was terminated or interrupted by small unlabeled gaps. For the second situation, we cannot be 100% sure which ones are connected to each other. In this sense, our tracing was performed at conservative criteria and showing underestimates. This point is now clarified in Materilas and methods section and Figure legends.

2\) Nevertheless, our tracing quality was at a similar level compared to Igarashi et al., 2012 and Ghosh et al., 2011 (Discussion section). We discussed the limitations and future challenged in a new subsection of Discussion section.

> Reviewer \#1:
>
> This manuscript is a revision of an earlier submission. The authors have taken serious steps to address the issues raised before and have in my view substantially improved the manuscript. The case for Tetbow being a significant step forward for multi-color neuronal labeling has been made more clearly.
>
> In particular, I think the added analyses of color assessment, comparison of fluorescence intensity to Brainbow; and importantly the analysis of color constancy over long distances (Figure 8 and associated supplements) are valuable and relevant.

We agree that the new sets of experiments have much strengthened the argument of this paper. We thank all the reviewers for constructive review process.

> Reviewer \#2:
>
> The revised manuscript, Tetbow: bright mutlicolor labeling of neuronal circuits with fluorescent proteins and chemical tags\" by Sakaguchi et al., addresses some of the points raised by the reviewers in the previous submission however, one significant concern remains.
>
> This methods paper adds to the existing toolkit for multicolor labeling of neurons. The tTA-TRE based reagents described in this manuscript appear to have improved brightness over the traditional Brainbow methods. While such a color palette would certainly be useful for answering certain neuroanatomical questions the revised manuscript still fails to address the primary concern that was raised in the original submission -- whether such a multicolor labeling approach would be useful for complete neuronal reconstructions. Will the use of multicolor labeling permit reconstruction of entire neurons at higher densities as the authors suggest, i.e. is it an improvement over existing methods that simply use sparse and bright neuronal labeling with a limited color-set.
>
> Figure 8 and Figure 8---figure supplement 2 in this revised submission address this question. The data presented clearly show that the trajectories of the main axon of multiple M/T neurons can be traced. This might be useful if the goal was to identify the primary brain areas targeted by these neurons. But it is not at all clear from the data shown whether complete reconstructions of neurons would be feasible and therefore prompts the question if Tetbow labeling is bright enough to trace axonal arbors in entirety. Reconstructions that aim to trace out only the main axon and the first order collaterals are already possible even in Thy1-GFP transgenic animals (see for instance Guo et al., (2017)). The authors would have definitely compared their traced neurons to the Mitral/Tufted cell reconstructions presented in Igarashi, 2012 or Ghosh, 2011 (both articles are cited in the manuscript). Is it possible to get similar level of completeness using the Tetbow approach?

In the conventional light microscopy, imaging resolution is limited, particularly along z-axis. Therefore, it is often difficult to distinguish two fibers crossing over along z-axis. Multicolor labeling is more reliable for tracing at longer distances, as has been quantitatively demonstrated in Figure 8---figure supplement 1.

As detailed above, it is almost impossible to know by any methods where the real terminal is. What we can say for now is that we traced axons with very conservative criteria, and our tracing performance was at a similar level compared to Igarashi et al., 2012 and Ghosh et al., 2011. We could find labeled axons in all the areas of the olfactory cortices we examined, including the olfactory tubercle, piriform cortex, cortical amygdala, and lateral entorhinal cortex (now in Discussion section). We could also find several axon collaterals in each mitral cell, which was comparable to these earlier studies. Of course, the single neuron labeling approach (Igarashi et al., 2012) has some advantages, e.g., robustness against interrupted labeling. On the other hand, our multicolor labeling approach has an advantage for the comparison of multiple neurons in the same animal. We could more clearly demonstrated heterogeneity of axonal projection patterns than earlier works. This point is now more extensively discussed in the revised text (Discussion section).

> Reviewer \#3:
>
> Sakaguchi et al., present a revised version of their article on the development of an enhanced multicolor neuronal labeling toolbox termed \"Tetbow\". They have significantly strengthened their study, \[...\] The tools presented in the manuscript and the efforts made at characterizing optimal labeling conditions will be of interest for the neuroscience community.

We appreciate favorable comments on our revision.

> My main comment about this new version of the article concerns the presentation of the results, which requires significant revision of the text for the following reasons:
>
> -Several concepts presented in the article are not novel per se and are simply improved and more deeply explored than in the studies that introduced them. The true interest of the article lies in these improvements and optimizations, which will undoubtedly be useful to the community, not in the rediscovery of previous ideas. This is for instance the case of multicolor labeling with mixtures of distinct single-color viral vectors (Chan et al., 2017; Weber et al., 2011) or plasmids (Siddiqi et al., 2014), modeling of the relationship between copy number and color (Kobiler et al., 2010), usage of the Tet-Off system to amplify expression in a multicolor context (Chan et al., 2017 and other studies)...When introducing these concepts, the text should state this explicitly and refer to the related articles. It is with respect to these recent studies that the new tools should be judged, not only relative to former Cre-dependent Brainbow approaches.

We totally agree with this reviewer. This is the first application of multicolor labeling in cleared tissues without further antibody labeling, but conceptually just the combination of existing ideas. We also apologize for our oversight of Siddiqi et al., 2014; this is now cited (subsection "A trade-off between expression levels and color variation"). We have also deleted the following sentence in the Results section: "We therefore tried to develop a multicolor labeling method for vector-mediated gene transfer". Chan et al., 2017 successfully utilized Tet-Off system to sparsen the expression of XFPs, but did not show any quantitative evidence for amplified expression for XFPs. We therefore only cited Madisen, 2015 and Sadakane, 2015, which demonstrated improved fluorescence intensity quantitatively.

> \- The discussion should also include a section on the drawbacks of Tetbow and possible difficulties of this approach, such as the necessity to carefully titrate the different RGB vectors to equilibrate their concentration, batch-to-batch variations, and whether it is compatible with strategies to sparsen expression e.g. as in Chan et al., 2017.

We agree that we should state the limitations of our method in a section of Discussion section. As detailed in the previous rebuttal letter, batch-to-batch variation is not a major issue. Current limitations include filling performance and color consistency that would be required for automatic tracing in the future. These issues are now discussed with possible future solutions (subsection "Single axon tracing for long-range axonal projections"). The utility of the Tet-Off system for sparse expression is discussed in subsection "Bright multicolor labeling of neurons using Tet-Off system".

> -Some statements are repeated unnecessarily throughout the paper (e.g. the known fact that Cre recombination is not required for combinatorial labeling).

This statement has been entirely removed from the Discussion section, as suggested. Throughout the text, we tried to minimize redundant statements.

> \- Several sentences are quite imprecise, some conclusions are overstated and there are also many typos that need to be corrected.

We apologize for any difficulty in understanding due to poor descriptions and typos that appeared in the previous version. We have carefully proofread this revision.
